10.04.2013 Views

Study of respiratory symptoms among sputum positive

Study of respiratory symptoms among sputum positive

Study of respiratory symptoms among sputum positive

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

flctnowfedgment<br />

;;r.:: First <strong>of</strong> all I thank ALLAH the All Mighty, the Gracious, all<br />

knowing for his aid and guidance.<br />

My extreme thanks and gratefulness to the pioneer (])r: .Jllimecf<br />

jf.mr 9Vl. rr: 5tto6aslier pr<strong>of</strong>essor <strong>of</strong>Chest Diseases Zagazig Faculty <strong>of</strong><br />

Medicine, for his great effort, guidance, and moral support all through this<br />

work.<br />

I'd like to express my deepest gratitude to CDr. CEnsaf.Jl6tfef<br />

\ qawacf .Jlzazy, pr<strong>of</strong>essor <strong>of</strong> Bacteriology Zagazig Faculty <strong>of</strong><br />

Medicine for his valuable supervision, continuous encouragement all<br />

through this study.<br />

My thanks and appreciation to Dr. qelian Safali Osman<br />

lecturer <strong>of</strong> Chest Diseases Zagazig Faculty <strong>of</strong> Medicine for her strict<br />

supervision and revision <strong>of</strong>work.<br />

My thanks and appreciation to a»: ::Mostafa Ibrahim<br />

"=1 (j{alJa6 lecturer <strong>of</strong> Chest Diseases Zagazig Faculty <strong>of</strong>Medicine for his<br />

-, ·1.<br />

patience and strict supervision and his invaluable advice helped me a lot.<br />

My appreciation to CDr. Hosam .J/.f-5liar!ig.1V), assistant<br />

pr<strong>of</strong>essor <strong>of</strong>Bacteriology Faculty <strong>of</strong>Medicine, Zagazig University, for his<br />

help in practical part <strong>of</strong>bacteriology.<br />

Finally, more thanks for all the staff<strong>of</strong>Chest Department, Zagazig<br />

Faculty <strong>of</strong> Medicine, especially t». WflJ{FD 9rt(YJ{)I9rt9rtp.([)<br />

S:J{oV:M..J/.!N for his great help and support. my patients, my colleagues,<br />

nursing staff and thanks to every one made any effort for this work to be a<br />

reality.


CONTENTS<br />

• Introduction and aim <strong>of</strong> the work ---------------------------- 1<br />

• Review <strong>of</strong> Literature --------------------------------------------- 4<br />

Tuberculous mycobacteria -------------------------------- 4<br />

Components <strong>of</strong> tuberculous lesion --------------------- 10<br />

Pulmonary tuberculosis ----------------------------------- 23<br />

Primary pulmonary tuberculosis ------------------<br />

Post primary pulmonary tuberculosis 32<br />

Miliary tuberculosis 40<br />

Diagnosis <strong>of</strong> pulmonary tuberculosis-------------------- 44<br />

• Patients and methods -------------------------------------------- 67<br />

• Res ults -------------------------------------------------------------- 81<br />

• Discussion ---------------------------------------------------------- 113<br />

• Summary and conclusion -------------------------------------- 129<br />

• Recommen dati0 ns ------------------------------------------------ 136<br />

• References --------------------------------------------------------- 137<br />

• APpen dix ----------------------------------------------------------- 177<br />

• Arabic Summary -------------------------------------------------<br />

Page<br />

26


......-r...<br />

ABBREVIAnONS


I *<br />

************************<br />

* *<br />

* }l66reviations *<br />

* JlC'l{ *<br />

Acquired cellular resistance<br />

'* JlCD}l<br />

JlPCB<br />

Adenosin deaminase<br />

Acid fast bacilli<br />

*<br />

*'<br />

: .J/-fCDS<br />

'*'<br />

*<br />

Qf CIA<br />

*flJn •<br />

}l'I'S<br />

*' C13JlL<br />

*' C13Cq<br />

'* cBSJl<br />

Acquired immune deficiency syndrome<br />

Alveolar macrophage.<br />

American Thoracic Society<br />

Broncho - alveolor lavage<br />

Bacillus calmette guerin<br />

Bovine serum albumin<br />

*<br />

:<br />

* *'<br />

*'<br />

*'<br />

'*<br />

: anc Center disease control and prevention :<br />

* *<br />

: C'M1<br />

*'CPC<br />

Cell - mediated immunity<br />

Cetyl pridinium chloride *'<br />

:<br />

: CSp<br />

'* CI<br />

Cerprospinal fluid<br />

Computrazid tomography<br />

:<br />

*'<br />

'* CI£ Cytotoxic T lymphocyte *'<br />

* *<br />

'* C¥Qt Chest X ray '*<br />

: rJ)9v! Diabetes mellitus :<br />

*' (J)J{}l Deoxy Nucleic acid '*<br />

: rJ)TJ[ Delyed type hypersensitivity :<br />

* *' - *<br />

************************<br />

j


I<br />

.'X<br />

,<br />

.. 'I.....<br />

-<br />

_1-<br />

I '*<br />

************************<br />

*' (p:JtD Purified protein derivative *'<br />

* *'<br />

*' PSCB Phosphate buffer saline *'<br />

: Sr:D Standard deviation :<br />

* 7'(}3 Tuberculosis *'<br />

: ry(]3S}l Tuberculostearic acid :<br />

: crqP(]3 Transforming growth factor B :<br />

cy'1fP Tumor necrosis factor *'<br />

* 7'V Tuberculin unit *'<br />

: VS}l United states <strong>of</strong>America :<br />

: 'f/'}l/Q Ventilation I<br />

'*<br />

perfusion :<br />

*'<br />

rvCJI.5W<br />

*<br />

Vascular cell adhesion molecule<br />

*'<br />

Wc.BCs White Blood Cell<br />

*' *'<br />

1IVJ[o World Health Organization<br />

* *'<br />

'* A2 *'<br />

Chi - square<br />

'* *' z. rrsp '*<br />

Zephiran. Trisodium phosphate.<br />

: Z.:N: Ziehel-neelsen :<br />

'* *' *'<br />

* *<br />

*'<br />

'*<br />

* *'<br />

'*<br />

'*<br />

*'<br />

'*<br />

*'<br />

'* *'<br />

'* *<br />

************************<br />

II


INlTRODUCTION<br />

AND<br />

AIM OF THE \\fORK


J_-<br />

IntnJducttOn<br />

The most important factor responsible for the increased rates <strong>of</strong>TB<br />

IS the pandemic <strong>of</strong> HlV infection (Telzak, 1997).The pandemic <strong>of</strong>HIV<br />

infection has changed tuberculosis, an endemic disease, to an epidemic one<br />

world wide (Barnes, 1997).The risk <strong>of</strong>developing active tuberculosis for<br />

dually infected person in calculated to be 30 times higher than person<br />

infected only with M. tuberculosis (Harries and Maher, 1996).<br />

Diagnosis <strong>of</strong> pulmonary tuberculosis (TB) made by many means<br />

clinical, radiological, skin testing, serology, bacteriology and pathology.<br />

The first 4 give picture <strong>of</strong> suspicious, bacteriology and pathology confirm<br />

the diagnosis. bacteriological diagnosis and serology (except direct smear<br />

examination <strong>of</strong> <strong>sputum</strong>) are expensive and may take long period as culture<br />

(Mobasher, 1993). Many authors hope to settle rules for early diagnosis <strong>of</strong><br />

tuberculosis and pick up the cases. The American Thoracic Society<br />

(ATS) (1992) and Centers for Disease Control and prevention (CDC),<br />

have recommended that " pulmonary tuberculosis should always be<br />

included in the differential diagnosis <strong>of</strong>persons with pulmonary signs or<br />

<strong>symptoms</strong> and appropriate diagnostic measures should be instituted",<br />

CDC (1994) have issued guidelines on the prevention <strong>of</strong> TB<br />

transmission in work place these guidelines emphasize the need for<br />

controls, the most important being the early identification <strong>of</strong>patients with<br />

active TB, in this sequence Cohen et al. (1996) found a significant<br />

correlation between <strong>symptoms</strong> <strong>of</strong>cough, <strong>sputum</strong> and weight loss and smear<br />

<strong>positive</strong> for TB. In our locality Mobasher et al. (1997) found that<br />

radiological picture was the corner stone on which the specialists depend in<br />

the diagnosis <strong>of</strong>pulmonary TB. National Tuberculosis Control Program<br />

(1998) stressed that annual risk <strong>of</strong>infection in Egypt was 16/100,000 and<br />

the total number <strong>of</strong>new smear +ve cases was 9,920 case.<br />

2


·1. v ·<br />

R£\fIEYi<br />

OF<br />

UT£RATUR£


Tuberculous Mycobacteria<br />

The most common agent <strong>of</strong>pulmonary tuberculosis is the acid fast<br />

bacillus M.TB. It's a species <strong>of</strong> the genus mycobacterium, family<br />

mycobacteriacae, order actinomycetales (Jeraff, 1986). There are five<br />

closely related mycobacteria grouped in the M. tuberculosis complex: M.<br />

tuberculosis, M. bovis, M. africanum, M. microti and M. canetti<br />

(Vansoolingen et aI., 1997 and 1998).<br />

Morphology and growth requirements:<br />

Mycobacterial tuberculosis (M.TB) is a slender, straight or slightly<br />

curved rod, 0.5 I-l in length and 0.34 ).l in breadth. The bacilli are non<br />

motile, gram <strong>positive</strong>, aerobic, and do not form spores or capsules (ATS,<br />

1987). The growth requirements <strong>of</strong> mycobacteria on artificial media<br />

include potassium, magnesium, phosphorus, and sulfur. Ammonium salts<br />

or egg ingredients provide a nitrogen source, and glucose or glycerol<br />

supply a carbon source. The optional pH range for growth is 6.5 to 7.0.<br />

Although mycobacteria are strict aerobes, a CO2 concentration between 5 %<br />

and 10 % is necessary for their primary recovery on solid media. The<br />

incubation conditions should include high humidity and atemperature <strong>of</strong><br />

35 to 37°C (Zheng and Roberts, 1999).<br />

Cell wall structure:<br />

The cell envelope essentially distinguishes species <strong>of</strong> the<br />

. I mycobacterium genus from other prokarytes. Mycobacteria in general give<br />

.W<br />

a weakly <strong>positive</strong> response to the gram stain,are phylogenetically more<br />

closely related to gram <strong>positive</strong> bacteria (Draper, 1982), and lackthe<br />

4


1@ww<strong>of</strong>£iterature<br />

classic endotoxic lipopolysaccharide associated with gram negative<br />

bacteria. However, similarties to gram negative cell walls include the<br />

paucity <strong>of</strong> peptidoglycan and the fact that mycobacterial cell walls contain<br />

meso-diaminopimelic acid (DAP) and an outer lipid barrier. This<br />

mycobacterial cell walls exhibit many <strong>of</strong> the characteristics <strong>of</strong> gram<br />

<strong>positive</strong> bacteria and some qualities <strong>of</strong> gram negative bacteria, but most<br />

importantly, possess their own unique features (McNeil et al., 1994).<br />

The cell wall <strong>of</strong> mycobacteria is composed <strong>of</strong>three layers enclosing<br />

a plasma membrane, which is also a three- layered structure. Chemically,<br />

the wall is very complex, and unlike <strong>of</strong> either gram <strong>positive</strong> or gram<br />

negative organisms, it contains an abundance <strong>of</strong> complex lipophilic<br />

macromolecules, many <strong>of</strong> which are unique to the organism and are<br />

biologically very active (Brennan, 1989).<br />

The most distinctive attribute <strong>of</strong>the mycobacterial cell envelope is<br />

the mycolic acid. In case <strong>of</strong> mycobacterium tuberculosis, the mycolic acid<br />

contain 70 to 90 carbon atoms (Minnikin and Good Fellow, 1980). They<br />

constitute more than 50% by weight <strong>of</strong>the mass <strong>of</strong>isolated cell envelops<br />

and apparently interact via powerful hydrophobic binding to form a lipid<br />

shell surrounding the organism. This property is undoubtedly responsible<br />

for the lipid barrier and consequent endogenous resistance to know drugs<br />

(McNeil et aI., 1994).<br />

Lipids account for approximately 60% <strong>of</strong>the dry weight <strong>of</strong>the wall<br />

and c<strong>of</strong>er properties that enable the organism to resist adverse<br />

environmental conditions. The backbone <strong>of</strong>the mycobacterial cell wall is a<br />

covalent structure consisting <strong>of</strong> two polymers covalently linked by<br />

phosphodiester bonds, a peptidoglycan and an arabinogalactan, to this<br />

5


qrwwo/£iterttlUW<br />

covalent structure, a large number <strong>of</strong>other complex materials are attached,<br />

which are responsible for immunogencity and tuberculin activity <strong>of</strong>wall<br />

preparation. The most important <strong>of</strong> them are wax D., cord factor, sulfatides,<br />

mycosides and poly. L. glutamic acid (Brennan, 1989).<br />

Antigenic structure:<br />

Mycobacteria contain many umque immuno-reactive substances,<br />

most <strong>of</strong> which are components <strong>of</strong>the cell wall (Goren, 1982). In spite <strong>of</strong><br />

intensive study for more than 50 years the antigenic composition <strong>of</strong>M. TB<br />

is not clearly defined (young et al., 1985). Immuno - reactivity has been<br />

demonstrated in lipids, polysaccharides and protein components. Since<br />

protective immunity to mycobacterial infections is mediated primarily by<br />

the cellular arm <strong>of</strong> the immune system proteins are regarded as the key<br />

immunogens. Few antigens that compose this complex mosaic have been<br />

obtained in chemically pure form to permit full evaluation <strong>of</strong> their<br />

immunolgic potential (Edward and Kirkpatrick, 1986).<br />

• The most common antigenic mycobacterial substances include:<br />

1- Polysaccharides : The protein - free polysaccharides (arabinogalactans<br />

and arabinomannans) are immunogenic and serologically active. The<br />

significance <strong>of</strong> these humoral antibodies, however, has not been<br />

established (Brennan, 1989).<br />

2- Phosphatidyl Inositol Mannosides (PIMS) : These are a family <strong>of</strong><br />

amphipathic polar lipids, present in the plasma membrane <strong>of</strong><br />

..<br />

_L mycobacteria and related organisms. They serve an important structural<br />

role. There is renewed interest in these components, and a beliefthat<br />

they are important lipoteichoic acid - like polymers with a role in<br />

6


-..........<br />

?ifui:w <strong>of</strong>£iter4tt1n<br />

Secreted antigens can serve important functions for bacterial<br />

survival. They are grouped into (Orme et aI., 1993) :<br />

(I) Proteins functioning at the bacterial surface or outside the bacterium,<br />

like the three fibronectin - binding proteins <strong>of</strong>the antigen 85 complex<br />

or superoxidedismutase.<br />

(2) Cell wall proteins which become released, like the 38 KDa<br />

glycolipoprotein or the Lulanine dehydrogenase protein.<br />

-<br />

The following is a group <strong>of</strong>M. TB antigens which are listed in the<br />

WHO bank :- Heat shock proteins 71 KDa, 65 KDa, 14 KDa, and 12KDa,<br />

phosphate biding protein 38 KDa, L- alanine dehydrogenase 44 KDa,<br />

membrane- associated 35 KDa protein, Fibronectin-binding protein 55KDa<br />

and 30/31KDa, potential signal peptide 19 KDa, 14 KDa protein, 10KDa<br />

protein, 100 KDa protein, 45 KDa protein. 47 KDa protein, and 43KDa<br />

protein (Richeldi et aI., 1995).<br />

9


antigen-specific receptors in the bone marrow, when exposed to the antigen<br />

for which they have a receptor, these T and B cells respond by clonal<br />

proliferation, greatly increasing their number.<br />

In tuberculosis, T cells appear to have two main functions<br />

(Dannenberg, 1999) :<br />

(l) Killing poorly activated rnacrophages In which the bacilli are<br />

multiplying.<br />

(2) Producing cytokines that activate macrophages can now kill or inhibit<br />

ingested bacilli.<br />

B cells produce antibodies, the production <strong>of</strong>which is enhanced by<br />

differentiation into plasma cells. Plasma cells are frequently found in<br />

tuberculous lesions. B cells (when activated) also increase the production<br />

<strong>of</strong>IFN-y by NK cells (Yuan et al., 1994).<br />

T cells can be divided into a variety <strong>of</strong> ways based on (Dannenberg and<br />

--_/ I Tomashefski, 1998) :<br />

(l) Their surface markers (CD4 and CDs T cells).<br />

(2) The cytokines they produce (Th, and Th 2 T cells).<br />

(3) Their functions (helper, regulatory and cytotoxic T cells).<br />

T cells can be divided into two subsets, Th, and Th2, on the basis <strong>of</strong><br />

the cytokines they produce (Mosmann & Sad, 1996 and Barish &<br />

1_-1 Rosewasser, 1997). Although some T cells show a mixed (i.e<br />

heterogeneous) cytokine pattern (Furie and Randolph, 1995).<br />

14


"<br />

L.<br />

@?wwo(L:iterature<br />

leukocytes are attracted into the area and then further activated. (Sugisaki,<br />

1998).<br />

Cytokines "knock-out" mice are mrce which the DNA for a<br />

particular cytokine or its receptor has been deleted from the genome. These<br />

mice have provided insights into the importance <strong>of</strong> various cytokines<br />

(Kaufmann and Ladel, 1994) (e.g. TNF-a) in acquired resistance to the<br />

tubercle bacillus. Some studies, can never prove that a given cytokine is<br />

completely responsible for such resistance because cytokines have many<br />

interaction with each other. Therefor, elimination <strong>of</strong>one cytokine affects<br />

many others in the network. In other words, the elimination <strong>of</strong> any other<br />

cytokine in the network could produce the same effect because <strong>of</strong> such<br />

interactions and interdependency (Kaufmann, 1995 and Cooper & Flynn,<br />

1995).<br />

Recombinant cytokines and cytokine inhibitors have found several<br />

clinical (Asnis & Gaspari, 1995 and Feldmann et al., 1996), and<br />

potentially clinical (Abbas et al., 1996) applications and are being<br />

evaluated in the treatment <strong>of</strong>tuberculosis (Johnson et al., 1996 and 1997).<br />

18


LJ I<br />

!((rWW0/Literature<br />

Immune mechanisms<br />

A) Cell-mediated immunity (Acquired cellular resistance) :<br />

Cell- mediated immunity (CMI) can be defined as a beneficial host<br />

response characterized by an expanded population <strong>of</strong> specific T.<br />

lymphocytes. That, in the presence <strong>of</strong> microbial antigens, produce<br />

cytokines locally. These cytokines attract monocytes/macrophages from the<br />

blood stream into the lesion and activate them, interferon-v (IFN- y) and<br />

tumor necrosis factor-a (TNF-a) are major macrophage-activating<br />

cytokines (Belosevic et al., 1988 and Celada & Nathan, 1994). INF-yalso<br />

induces interleukin 2 (IL-2) receptors in monocyte macrophages, after<br />

which IL-2 becomes an additional activating cytokine for these phagocytes<br />

(Holter et aI., 1987). Activated macrophages produce reactive oxygen<br />

(Kleban<strong>of</strong>f, 1988) and nitrogen intermediates (Liew and Cox, 1991),<br />

lysosomal enzymes, and other factors that kill and digest tubercle bacilli<br />

(Remick and Friedland, 1997). Acquired cellular resistance (ACR) is<br />

characterized by the presence <strong>of</strong> a local population <strong>of</strong> activated<br />

(microbicidal) macrophages, produced by eMI (Dannenberg, 1989) (i.e<br />

By the cytokines <strong>of</strong>antigen-stimulated lymphocytes) (Barnes et al., 1990).<br />

In the 1960, Machaness showed that acquired cellular resistance<br />

once produced, was non specific. Activated macrophages could destroy or<br />

inhibit many types <strong>of</strong> facultative intracellular bacteria, not just the type that<br />

caused their activation. However, once these activated macrophages have<br />

disappeared, following the healing <strong>of</strong> the primary infection, only the<br />

specific bacterial species could rapidly produce them a gain. This rapid<br />

"recall" response is due to the presence <strong>of</strong>expanded populations <strong>of</strong>long<br />

lived (i.e. non dividing) recirculating Th. lymphocytes (memory cells) with<br />

19


B) Delyed- type hypersensitivity (DTH)<br />

Delyed type hypersensitivity (DTH) is immunologically the same<br />

process as CMI, involving Th1- type T cells and their cytokines frequently<br />

use. The terms tissue damaging DTH or cytotoxic DTH to represent the<br />

immunologic reaction that causes caseous necrosis. Such necrosis develops<br />

locally wherever, the tuberculin-like antigens form the bacillus reach<br />

excessive concentration (Dannenberg, 1999). CMI and DTH immunologic<br />

processes produced by the host play key roles in the pathogenesis <strong>of</strong><br />

tuberculosis (Dannenberg, 1991). The relationship between CM! and DTH<br />

in the control <strong>of</strong>facultative intracellular microorganisms has been a subject<br />

<strong>of</strong> debate for most <strong>of</strong> 20 th century. From a histologic study <strong>of</strong> the<br />

tuberculous lesions and the bacillary growth curves it as apparent that both<br />

CMI and DTH inhibit the multiplication <strong>of</strong>the tubercle bacillus equally<br />

well. CMI does so, by activating macrophages to kill the bacilli they ingest.<br />

Tissue damaging DTH does so by destroying bacilli-laden, non activated<br />

macrophages and near by tissues there by eliminating the intracellular<br />

environment that is so favorable for bacillary growth (Luri, 1964 and<br />

Dannenberg, 1991).<br />

Thus, the immune system <strong>of</strong>both tuberculin <strong>positive</strong> hosts with good<br />

CM! and tuberculin <strong>positive</strong> hosts with poor CM! can arrest bacillary<br />

growth. The host with poor eMI does so, however, with much damage to<br />

its own tissues. Eventually, the host with good eMI may recover, but the<br />

host with poor CMI dies from excessive tissue destruction (Dannenberg,<br />

1999). Tissue-damaging DTH causing local necrosis stops the initial<br />

.i. I bacillary growth within nonactivated macrophages. Which gives the host<br />

time for eMI to develop local macrophage activation such cytotxic DTH<br />

can never take the place <strong>of</strong> CMI because the bacilli that escape from the<br />

21


. ,,/<br />

--...._- !<br />

edge <strong>of</strong> necrotic areas are ingested by perifocal macrophages. If the<br />

perifocal macrophages have been sufficiently activated by eMI, they can<br />

destroy the ingested bacilli. Otherwise, the bacilli again grow<br />

intracellularly until again tissue, damaging DTH kills the macrophages,<br />

enlarging the caseous necrotic area (Dannenberg, 1999).<br />

22


..... -. '..,<br />

gf{ww0/£iteratttn<br />

Pulmonary tuberculosis<br />

Transmission <strong>of</strong> pulmonary tuberculosis:<br />

For many years tuberculosis was thought to be transmitted<br />

genetically and even today patients who have little or no idea <strong>of</strong>theory <strong>of</strong><br />

infection when informed <strong>of</strong> the diagnosis <strong>of</strong> tuberculosis may express<br />

surprise because it's not in may family doctor (Seaton et aI., 1989).<br />

Riley (1974), found that tuberculosis is transmitted by air borne<br />

spread from person to person via infected <strong>respiratory</strong> secretions. Inhalation<br />

<strong>of</strong> droplet nuclei containing the tubercle bacillus may result in infection.<br />

Respiratory droplets are produced when someone with pulmonary<br />

tuberculosis coughs or in the case <strong>of</strong> laryngeal tuberculosis, with speaking<br />

or singing, While these <strong>respiratory</strong> droplets are air borne, water evaporates,<br />

leaving 1-5 urn particles called droplet nuclei. Because <strong>of</strong>their small size,<br />

these droplet nuclei may remain suspended in air currents for hours and,<br />

when inhaled may escape the host's. When these droplet nuclei reach the<br />

alveoli infection may result (Riley, 1974).<br />

Infectiousness <strong>of</strong>a tuberculous patient is dependent on the number <strong>of</strong><br />

tubercle bacilli expelled into the air. The bacilliary load is related to a<br />

number <strong>of</strong> factors, including presence <strong>of</strong> disease in the lungs, cavity<br />

formation, disease in the airways or pharynx, presence or induction <strong>of</strong><br />

cough. Failure <strong>of</strong> the patient to cover the mouth while coughing, and<br />

presence <strong>of</strong> AFB on microscopic examination <strong>of</strong><strong>sputum</strong> specimens. The<br />

period <strong>of</strong> infectiousness may be prolonged with in appropriate therapy <strong>of</strong><br />

tuberculosis (CDC 1990).<br />

23


I I<br />

Interpersonal spread <strong>of</strong> tuberculosis may be enhanced in areas <strong>of</strong><br />

overcrowding, poor air circulation, or recirculated, unfiltered air. Rates <strong>of</strong><br />

tuberculosis infection in exposed contacts <strong>of</strong> individuals with active<br />

tuberculosis may also be dependent on the duration <strong>of</strong> exposure (Onorato<br />

and Ridzon 1995). In a study <strong>of</strong> a student with laryngeal tuberculosis,<br />

infection was noted as little as 5 hours <strong>of</strong>exposure (Braden, 1995).<br />

Pathogenesis <strong>of</strong> pulmonary tuberculosis<br />

The development <strong>of</strong> pulmonary tuberculosis from its onset to its<br />

various clinical manifestations is dependent upon a series <strong>of</strong>interactions or<br />

"battles" between the host and the bacillary invader (Lurie, 1964 and<br />

Dannenberg 1993).<br />

An inhaled unit <strong>of</strong> one to three bacilli is ingested by an alveolar<br />

macrophage. Either the bacillus is destroyed before any lesion is produced<br />

or it multiplies within the alveolar macrophage, which dies and reduces the<br />

amplified infection agent. Many <strong>of</strong> the bacilli are then ingested by and<br />

grow within monocyte\macrophage that have emigrated from the blood<br />

stream. The cells accumulate at the site, fanning a microscopic lesion.<br />

When the host becomes tuberculin <strong>positive</strong> a caseous center develops in<br />

this lesion. A lesion with a small caseous center (up to 2mm in diameter)<br />

may enlarge or may heal (or stabilize) before it is detectable by<br />

radiography (Dannenberg and Tomashefski. 1998).<br />

A larger caseous lesion may also heal or stabilize, or it may enlarge,<br />

shedding bacilli into the blood and lymph. Alternatively, a caseous lesion<br />

may liquefy and form a cavity (from which the bacilli enter the bronchial<br />

tree). In the liquefied caseum, the bacilli will grow extracellularly (for the<br />

first time), and from the cavity they spread to other parts <strong>of</strong>the lung and to<br />

24


".<br />

!/(fWW<strong>of</strong>£itcrature<br />

Primary pulmonary tuberculosis<br />

The first infection with the tubercle bacillus is known as primary<br />

tuberculosis and usually includes involvement <strong>of</strong>the draining lymph nodes<br />

in addition to the initial lesion. The combination <strong>of</strong>the Primary or Ghon<br />

focus and the draining lymph nodes is known as the primary complex<br />

(Leitch, 2000).<br />

The Primary infection is associated with a small lesion in the lung.<br />

The location <strong>of</strong> which is determined by the distribution <strong>of</strong>ventilation and<br />

therefore is most common in the mid and lower zones. The organisms are<br />

taken up by macrophages and form a small area <strong>of</strong> consolidation with<br />

exudation and cellular infiltration, the pulmonary component <strong>of</strong> the<br />

primary or Ghon focus. At an early stage <strong>of</strong>the primary infection, possibly<br />

within a few hours, bacilli are transported through the lymphatics to the<br />

regional lymph nodes where there is a very marked reaction (Mc Nicol et<br />

al., 1995).<br />

Symptoms <strong>of</strong> primary pulmonary tuberculosis<br />

The great majority <strong>of</strong> primary tuberculosis infection are probably<br />

Symptomless, at least in young adults and adolescents (Daniels, 1948), the<br />

infection being overcome without the individual being aware <strong>of</strong> it. A<br />

proportion may experience a brief febrile illness at the time <strong>of</strong>tuberculin<br />

conversion which is indistinguishable from the many febrile illness <strong>of</strong><br />

childhood. Occasionally, typical primary tuberculosis may occur in elderly<br />

people who have lost their tuberculin sensitivity (Leitch, 2000).<br />

When tuberculosis is common primary infection is almost invariable,<br />

but it only produces <strong>symptoms</strong> in a minority < 10% and these <strong>symptoms</strong><br />

26


gf{wUJ<strong>of</strong>£iterature<br />

are not normally major (Me Nicol et al., 1995). In those cases, perhaps<br />

-" I those with more severe infection or low host resistance, the child may be<br />

unwell with loss <strong>of</strong>appetite, fretfulness and failure to gain weight. Cough<br />

is not usual, but may occur, and may mimic the paroxysms <strong>of</strong> whooping<br />

cough when lymph nodes or tuberculous granulation tissue impinge on the<br />

bronchial wall. Wheeze may be a result <strong>of</strong> the same process. Sputum<br />

production is rare in children (Seaton, 1989).<br />

Signs <strong>of</strong> primary pulmonary tuberculosis:<br />

In most cases there are no detectable physical SIgnS with severe<br />

disease. The child may appear unwell, fretful and debilitated. Auscultation<br />

<strong>of</strong> the chest is usually unrewarding but occasionally crepitation may be<br />

heard over an extensive primary focus and wheezes may result from<br />

pressure <strong>of</strong> glands on bronchi. More extensive physical signs may be<br />

present ifthere is segmental or lobar exudation or collapse (Seaton, 1989).<br />

Chest Radiology<br />

Radiological changes are found at the time <strong>of</strong> tuberculin conversions<br />

III 7-30% <strong>of</strong>young adults, being higher in those exposed to a known source<br />

<strong>of</strong> infection (Daniels 1948 and Davies, 1961). The prevalence <strong>of</strong><br />

radiological changes in children varies in different populations, in a<br />

Nigerian Series 79% had lymph adenopathy and 68% had parenchymale<br />

lesion (Aderele, 1980). In primary tuberculosis parenchymale involvement<br />

can happen in any segment <strong>of</strong> the lung (Weber, 1968 and Danek, 1979).<br />

The most common radiographic appearance <strong>of</strong>primary tuberculosis<br />

IS a normal radiograph. Hilar or paratracheallymph node enlargement with<br />

or without a parenchymal infiltrate is a characteristic finding in primary<br />

27


...... 1<br />

.L<br />

"......."--<br />

TB. In 15 % <strong>of</strong> the cases, bilateral hilar adenopathy may be present and<br />

could be confused with sarcoidosis. Usually, the adenopathy is unilateral.<br />

Unilateral hilar adenopathy and unilateral hilar and paratracheal<br />

adenopathy are equally common. Massive hilar adenopathy may herald a<br />

complicated course. Atelectasis with an obstructive pneumonia may result<br />

from bronchial compression by inflamed lymph nodes or from a caseous<br />

lymph node that ruptures in to a bronchus (Rossman and Oner-Eyuboglu,<br />

1998).<br />

In the primary infection then is only sight predilection for the upper<br />

lobes ; also, anterior as well as posterior segments can be involved. The air<br />

space consolidation appears as a homogeneous density with ill-defined<br />

borders, and cavitation IS rare except in malnourished or other<br />

immunocompromised patients. Miliary involvement at the onset occurs in<br />

less than 3% <strong>of</strong> cases, most commonly in children under 2-3 years <strong>of</strong>age<br />

(Rossman and Mayock, 1999).<br />

Complication <strong>of</strong> primary pulmonary tuberculosis:<br />

1) Progressive disease at the site <strong>of</strong>the lung lesion:<br />

This is uncommon but if it does occur it tends to proceed to<br />

cavitation and breakdown presenting as a typical tuberculous lesion but in<br />

an unusual site (McNicol et al., 1995).<br />

2) The formation <strong>of</strong>tubuerculoma :<br />

Occasionally the granulomatous lesion progresses slowly resulting in<br />

a circumscribed rounded lesion with surrounding fibrosis and <strong>of</strong>ten some<br />

calcification which persists indefinitely. The finding <strong>of</strong> such a lesion in<br />

later life may raise the suspicion <strong>of</strong> a carcinoma (McNicol et al., 1995).<br />

28


....<br />

£fwwoj"£itertltua<br />

3) Erythema nodosum :<br />

Erythema nodosum has been reported to have accompanied primary<br />

tuberculosis infection in 1-2(1'0 <strong>of</strong> British (Daniels, 1948 and Thompson,<br />

1952) and 5-15% <strong>of</strong> Scandinavian cases (Cr<strong>of</strong>ton, 1954). It is rare below<br />

the age <strong>of</strong> seven, with an increase in frequency up to puberty. It is<br />

commoner in girls than boys at all ages and after puberty 80.90% <strong>of</strong>cases<br />

are in females (Ustvedt, 1977).<br />

The characteristic feature <strong>of</strong> erythema nodosum is the presence <strong>of</strong><br />

tender dusky-red slightly nodular lesions on the anterior surfaces <strong>of</strong>the<br />

legs, although lesions are occasionally also found on the anterior surfaces<br />

<strong>of</strong> the thighs, the extensor surfaces <strong>of</strong>the forearms and rarely on the face<br />

and breasts. The nodules are usually 5-20 mm in diameter, have ill- defined<br />

margins and may become confluent. They usually resolve over a week or<br />

two, the red color fading to purple and then brown, the brownish pigment<br />

<strong>of</strong>ten persisting for several weeks. Recurrent crops <strong>of</strong>lesions may occur<br />

(Leitch, 2000).<br />

4) Phlyctenular conjunctivitis:<br />

This condition reflects hypersensitivity to the tubercle bacillus, but<br />

unlike erythema nodosum is not necessarily confined to the first weeks <strong>of</strong><br />

infection. It usually occurs within the first year (Price and McManus<br />

1943), is most <strong>of</strong>ten seen in children and is said to be commoner in those<br />

with poor social backgrounds and in non-European communities in Africa<br />

and America (Miller et al., 1963). The lesion is usually seen in one eye but<br />

may occur in both either simultaneously or successively. It begins with<br />

irritation, lachrymation or photophobia. The characteristic finding is <strong>of</strong>a<br />

small 1-3 mm shiny yellowish or grey bleb at the limbus with a sheaf <strong>of</strong><br />

29


....- I<br />

._. J<br />

f(fuew0/£iteroture<br />

dilated vessels runmng out towards it from the edge <strong>of</strong>conjunctival sac<br />

(Seaton, 1989).<br />

5) Bronchiectasis<br />

Distention by mucus, caseous tissue or secondary infection beyond a<br />

bronchial stenosis may result in bronchiectasis, especially following lobar<br />

or segmental lesions (Roberts and Blair, 1950). The incidence is reduced<br />

by prompt chemotherapy and by the use <strong>of</strong>corticosteriod drugs (Gerbeaux<br />

et al., 1965).<br />

6) Broncholith<br />

Calcification III a pnmary focus, or more commonly in a lymph<br />

node, may later be extruded into a brorchus as a broncholith, which may<br />

declare itself with haemoptysis. Such broncholith may be seen through the<br />

bronchoscope, but are best left well alone (Leitch, 2000).<br />

7) Pneumonitis / collapse:<br />

These radiological appearances are due to lobar or segmental<br />

consolidation/collapse, and are associated with enlarged tuberculous lymph<br />

nodes at the hilum. The middle lobe is most <strong>of</strong>ten affected. The<br />

radiographic appearances may be due to collapse, inflammatory exudation,<br />

caseous pneumonia or any combination <strong>of</strong> these. Collapse is produced<br />

either by pressure <strong>of</strong> the lymph node on the bronchus or by the spread <strong>of</strong><br />

tuberculosis granulation tissue into the bronchus with resultant stenosis or<br />

by discharge <strong>of</strong> caseous material from the lymph node through the<br />

bronchial wall (Seaton, 1989).<br />

30


-I<br />

..I<br />

1f[ww<strong>of</strong>£iterature<br />

The commonest cause is the inflammatory exudate, either monocytic<br />

or polymorphonuclear. Epithelial tubercles may also be present (Seal,<br />

1971). The exudate is probably due to the discharge <strong>of</strong>caseous material<br />

into the bronchial lumen with aspiration into a segment or lobe and a<br />

resultant exudative hypersensitivity reaction to the contained<br />

tuberculoprotein. Actual caseous pneumonia appears to be very unusual<br />

although small areas <strong>of</strong> caseation may occur (Cr<strong>of</strong>ton, 1954 and Leitch,<br />

2000).<br />

8) Pleural effusion<br />

Pleural effusion may sometimes accompany pnmary pulmonary<br />

tuberculosis in children under the age <strong>of</strong> puberty (Aderele 1980). Both<br />

pleural surfaces are then studded with tubercles and intensely inflamed.<br />

There is exudation <strong>of</strong> fluid and the pericardium may be similarly affected<br />

pleural and pericardial effusions tend to occur at or shortly after the time <strong>of</strong><br />

Iry infection and are regarded as complications <strong>of</strong>the lry lesion (McNicol<br />

et al., 1995).<br />

31


.....<br />

,t. I<br />

I<br />

¥rruew <strong>of</strong>Literature<br />

Predisposing Factors for TB (Seaton, 1989) :<br />

1) Nutrition: Malnutrition is believed to predispose to tuberculosis.<br />

2) Housing: Poor housing conditions with overcrowding such as still exist<br />

in many common lodging houses may contribute to the disease (Patel,<br />

1985 and Capewell, 1986).<br />

3) Occupation : Tuberculosis is commoner <strong>among</strong> the health service<br />

pr<strong>of</strong>essions due to an increased risk <strong>of</strong> exposure to the disease<br />

(Festenstein 1984 and Geiseler et al., 1987). Workers in occupations<br />

giving rise to pulmonary silicosis such as masons, quarry workers,<br />

knife, grinders and coalminers have a greater risk <strong>of</strong> developing<br />

tuberculosis (Snider, 1978 ).<br />

4) Alcoholism: Tuberculosis is common in alcoholics, contributory factors<br />

probably being malnutrition, adverse social factors and a direct effect <strong>of</strong><br />

alcohol on host defenses (Smith and Palmer, 1976).<br />

5) Cigarette smoking : Cigarette smoking is a principal cause <strong>of</strong><br />

preventable diseases and premature death world- wide. It is implicated<br />

in a large number <strong>of</strong> diseases in the different body systems. Smoking is<br />

considered as the chief contributor to chronic pulmonary disease in<br />

adults (Alcalde et al., 1996 ).<br />

The studies that were carried out to explore the role <strong>of</strong> smoking in<br />

developing active IB revealed controversial results, probably because <strong>of</strong><br />

the interference <strong>of</strong> other factors, such as age, alcohol consumption or<br />

socioeconomic status. However, a significant <strong>positive</strong> correlation was<br />

found between the degree <strong>of</strong>smoking and the release <strong>of</strong>intracellular and<br />

extra cellular reactive oxidants in peripheral blood (Richards et al., 1989).<br />

33


Also, smoking was recognized as a toxic factor capable <strong>of</strong>reducing host<br />

immune defense mechanism (Cr<strong>of</strong>ton et al., 1992), and reported to disturb<br />

oxidant lanti-oxidant homeostasis via attraction and stimulation <strong>of</strong><br />

macrophages and neutrophils liberating oxidants (Mobasher, 1993).<br />

6) Steriod and other immunosuppressent drugs In<br />

immunocompromised patients, tuberculosis is most <strong>of</strong>ten the result <strong>of</strong><br />

reactivation <strong>of</strong> a latent focus, but it is some times a primary infection.<br />

In such patients, tuberculosis is usually more sever and rapidly<br />

progressive than in immunocompetent patients, mortality is higher, and<br />

extrapulmonary involvement is more frequent (Barnes et al., 1991).<br />

In all immunosuppressed patients, the morphology <strong>of</strong>tuberculous<br />

lesions reflects poor host resistance. As, in corticosteriod- treated patients,<br />

tuberculous lesions show abundant caseation with little or no encapsulation<br />

or granulamatous reaction. Large numbers <strong>of</strong>bacteria are usually present<br />

within the lesions (Dannenberg and Tomasbefski, 1998 ).<br />

7) Other diseases : Diseases associated with impaired cellular immunity<br />

such as Hodgkin's disease, leukemia, lymphoma and AIDS may<br />

predispose to reactivation (Lovie et al., 1986 and Handwerger et aI.,<br />

1987). Diabetes mellitus potentiates TB through (Mobasber, 1993) :<br />

a) compromising the host defense mechanisms.<br />

b) Producing local tissue acidosis and electrolyte imbalance, that impair<br />

repair.<br />

c) Favoring the growth and viability <strong>of</strong> the bacilli by increasing sugar<br />

glycerol and nitrogenous substances in the blood<br />

34


.... -<br />

-i<br />

1ffview<strong>of</strong>£iterature<br />

• N.B.<br />

Dannem berg and Tomaihefski (1998), considered the exogenous<br />

reinfection and Haematogenous spread <strong>of</strong>disease as adult tuberculosis.<br />

Clinical Features <strong>of</strong> post-primary pulmonary tuberculosis<br />

TB as:<br />

Leitch (2000), summarized <strong>symptoms</strong> presentations <strong>of</strong>post primary<br />

1) Symptom free discovered on routine radiography.<br />

2) Persistent cough ± <strong>sputum</strong>.<br />

3) General malaise<br />

4) Weight loss.<br />

5) Recurrent colds<br />

6) Pneumonia which proves to be tuberculous.<br />

7) Haemoptysis<br />

Mc Nicol et al. (1995), found that symptom, <strong>of</strong> TB unlike disease<br />

such as asthma where the <strong>symptoms</strong> are characteristic and the diagnosis is<br />

based on the history, the <strong>symptoms</strong> <strong>of</strong>tuberculosis are non-specific and<br />

generally do no more than point to the need for investigation. It is also clear<br />

that active disease may be present without any <strong>symptoms</strong> at all. Early<br />

diagnosis and treatment demand a high index <strong>of</strong> suspicion.<br />

The significance <strong>of</strong>the <strong>symptoms</strong> depend very much on the patient,<br />

the adolescent or young adult with a subacute illness with fever, weight<br />

36


loss and persistent productive cough almost certainly has the disease if he<br />

or she lives in an area where tuberculosis is endemic or if he or she is a<br />

member <strong>of</strong> a group that has a high incidence <strong>of</strong>the disease, such as some <strong>of</strong><br />

immigrant communities in developed countries. The same <strong>symptoms</strong> in a<br />

native <strong>of</strong> a developed country would not immediately suggest the diagnosis<br />

and it would be more useful to consider other possibilities first (McNicol et<br />

al., 1995).<br />

Rossman and Mayock (1999), divided the <strong>symptoms</strong> into two<br />

categories constitutional and pulmonary. The most common constitutional<br />

symptom is fever, low grade at the onset but becoming marked ifthe<br />

disease progresses. Characteristically, the fever develops in the late<br />

afternoon and may not be accompanied by pronounced <strong>symptoms</strong> with<br />

defervescence, usually during sleep, sweating occurs. The classic (night<br />

sweats) other signs <strong>of</strong> toxemia such as malaise, irritability, weakness,<br />

unusual fatigue, headache and weight loss, may be present with the<br />

development <strong>of</strong> caseation necrosis and concomitant liquefaction, <strong>of</strong>the<br />

"'1 caseation, the patient usually notices cough and <strong>sputum</strong>, <strong>of</strong>ten associated<br />

LI I<br />

with mild haemoptysis. Chest pain may be localized and pleuritic.<br />

Shortness <strong>of</strong> breath usually indicates extensive disease with wide spread<br />

involvement <strong>of</strong> the lung and parenchyma or some form <strong>of</strong>tracheobronchial<br />

obstruction and therefore usually occurs late in the course <strong>of</strong>the disease.<br />

Physical signs<br />

There may be no physical signs in pulmonary tuberculosis even with<br />

relatively advanced disease but there may be pallor, a hectic flush or<br />

cachexia in sever disease (Leitch, 2000). Physical examination <strong>of</strong>the chest<br />

is <strong>of</strong>ten completely normal early in the disease. The principal finding over<br />

37


kfrwwo/£itertlture<br />

In 95 percent <strong>of</strong> localized pulmonary TB, the lesions be present in<br />

the apical or posterior segment <strong>of</strong>the lower lobes, although reactivation TB<br />

may affect any lung segment (Rossman, and Mayock, 1999). Although<br />

Poppius and Thomander (1957), found that the anterior segment <strong>of</strong>the<br />

upper lobe is almost never the only manifested area <strong>of</strong>involvement. And<br />

David (1976), also found, if only the anterior segment <strong>of</strong>the upper lobe is<br />

affected, TB is extremely unlikely.<br />

The most common pattern <strong>of</strong>reactivation TB is <strong>of</strong>a focal air spaces.<br />

Consolidation in patchy or confluent nature. Frequently, linear densities<br />

connect to the ipsilateral hilum. Cavitation is common, but lymph node<br />

enlargement is rare. Because the lesions are usually chronic, destruction <strong>of</strong><br />

tissue, fibrosis, calcification, and volume loss are usually present in the<br />

affected lung. The combination <strong>of</strong>patchy pneumonitis fibrosis calcification<br />

should always suggest chronic granulomatous disease, usually TB<br />

(Rossman and Oner-Eyuboglu, 1998).<br />

The cavities that develop in tuberculosis are characterized by a<br />

moderately thick wall, a smooth inner surface, and the lack <strong>of</strong> an air-fluid<br />

level. Cavitation is frequently associated with endobronchial spread <strong>of</strong><br />

disease. Radiographically, it appears as multiple small aciner shadows<br />

endobronchial spread may produce extensive areas <strong>of</strong>bronchopneumonia.<br />

(Rossman and Mayock, 1999).<br />

39


--<br />

1(rVliwoj"£iteratttre<br />

Miliary Tuberculosis<br />

Miliary tuberculosis defines the presence <strong>of</strong> innumerable, tiny,<br />

discrete tuberculous lesions in the lungs and other organs owing to the<br />

seeding <strong>of</strong> these tissues by blood borne tubercle bacilli. The word (miliary)<br />

was used originally by John Jacob Manget in 1700 to denote the small size<br />

<strong>of</strong> such lesions, generally less than 2 mm in diameter or approximately the<br />

size <strong>of</strong> millet seeds (Sahn and Neff, 1974).<br />

Miliary tubercles may be <strong>of</strong>two types, depending on the resistance<br />

<strong>of</strong> the host. The compact (hard) tubercle with epithelioid cells and<br />

occasional giant cells (i.e. The proliferative type <strong>of</strong> lesion with or without<br />

caseous centers) and the loosely formed exudative type or (s<strong>of</strong>t) tubercle.<br />

The exudative type contains more bacilli, which continue to multiply. This<br />

type usually undergoes early and complete caseation and progresses<br />

rapidly. Tubercles with mixed hard and s<strong>of</strong>t characteristics are also<br />

common (Dannenberg and Tomashefski, 1998).<br />

Symptoms <strong>of</strong> miliary tuberculosis:<br />

The clinical presentation <strong>of</strong> miliary tuberculosis may vary<br />

significantly. Common <strong>symptoms</strong> include fever, weakness, anorexia,<br />

weight loss, and cough. Fever may be continuous but is <strong>of</strong>ten low grade<br />

and intermittent. Fever is common even <strong>among</strong> patients with underlying<br />

malignancy and in those immunosuppressed from cancer, chemotherapy or<br />

other causes. Less common <strong>symptoms</strong> include headache, abdominal pain,<br />

and dyspnea. Headache is ominous and <strong>of</strong>ten signifies the presence <strong>of</strong><br />

tuberculous meningitis (Munt,1971 and Prout & Benatar, 1980).<br />

40


.----. i<br />

-,,-' .l<br />

Abdominal pam IS less specific but has been associated with<br />

involvement <strong>of</strong>the peritoneum or partial intestinal obstruction secondary to<br />

lymph node or omental involvement. Dyspnea, when present, may be the<br />

result <strong>of</strong> underlying lung disease or <strong>of</strong>decreased diffusing capacity 2ry to<br />

extensive interstitial tubercles (Williams et al., 1973). The <strong>symptoms</strong> are<br />

usually protracted, averaging between 3 and 15 weeks except, in<br />

immunosuppressed patients or those with serious co-existing disease in<br />

whom the onset may be more abrupt (Divinagracia and Harris, 1999).<br />

Physical signs:<br />

The signs most <strong>of</strong>ten present on physical examination III elder<br />

include fever, tachycardia, and adventitious sounds on pulmonary<br />

examination. Splenomegaly and lymphodenopathy, although common m<br />

children, frequent findings in adult. Hepatomegaly is common; studies<br />

from Groote shur Hospital in South Africa documented hepatomegaly in<br />

50% to 65% <strong>of</strong>patients, most <strong>of</strong>whom are adults (Maartens et aI., 1990).<br />

Choroidal tubercles are gray, gray-whit, or yellowish lesions usually less<br />

than one quarter the size <strong>of</strong>the optic disc and appearing within 2 mm <strong>of</strong>the<br />

optic nerve. They are usually multiple bilateral, with one to five found in<br />

the choroid <strong>of</strong> both eyes. Histologically they are similar to other<br />

tuberculous lesions and may be either caseating or non caseating<br />

granuloma (Massaro et aI., 1964).<br />

Cutaneous manifestations <strong>of</strong> miliary tuberculosis are discrete, dull<br />

erythematous macules and papules that are initially the size <strong>of</strong>a pin head.<br />

They may become capped by tiny vesicles that after rupturing, have<br />

papules with a central crust. The lesions are most frequently localized on<br />

thighs, buttocks, genitalia, and extremities. They usually number no more<br />

41


or I<br />

than 20-30. More than 20 cases have been repeated and in one case, this<br />

cutaneous manifestation was the only sign <strong>of</strong> inadequate antituberculous<br />

therapy (Rietbroek et aI., 1991).<br />

Chest radiographs:<br />

The chest radiograph IS the single most important means for<br />

detecting miliary tuberculosis. The classic pattern <strong>of</strong> diffuse, bilateral,<br />

symmetrical, discrete, pinpoint 2 to 3 mm densities. Some <strong>of</strong>the apparent<br />

variations in the size <strong>of</strong>the lesions are due to densities in various depths <strong>of</strong><br />

the lung parenchyma superimposed on the chest film. At first the tiny<br />

nodules may have faint, hazy outlines, but they sharpen as they grow<br />

larger. Often they appear more numerous at the central and basal areas <strong>of</strong><br />

the film because <strong>of</strong> the greater thickness <strong>of</strong> the lung at these sites<br />

(Divinagracia and Harris, 1999).<br />

Classification <strong>of</strong> tuberculosis:<br />

Information derived from the history, physical examination, PPD<br />

-... _I tuberculin skin test result, chest radiograph, and microbiological studies is<br />

4-1 I<br />

used to classify TB case. Classification scheme used by the American<br />

Thoracic society and CDC is provided as (Gochuico and Bernardo,<br />

1997):<br />

Class 0<br />

Class I<br />

Class 2<br />

Class 3<br />

No exposure; no infection<br />

exposure; no infection<br />

Infection, no disease (i.e, +ve PPD reaction but no evidence <strong>of</strong><br />

active TB)<br />

Disease, clinically active<br />

42


£(ww0L£iterature<br />

Class 4<br />

Class 5<br />

Disease, not clinically active (i.e. evidence <strong>of</strong>previous TB or<br />

following therapy for tuberculous disease).<br />

Suspected disease, diagnosis pending<br />

Classification <strong>of</strong>a given case allow stratification that aids in that aids<br />

In the monitoring <strong>of</strong> treatment and the development <strong>of</strong> epidemiologic<br />

pr<strong>of</strong>iles by Public health <strong>of</strong>ficials.<br />

43


it<br />

fifuew oj"£iterature<br />

Diagnosis <strong>of</strong> pulmonary TB<br />

The diagnosis <strong>of</strong> pulmonary tuberculosis is not easy. Clinical signs<br />

are non specific and may be confused with many chest diseases.<br />

Radiological changes increase the suspicion <strong>of</strong> pulmonary tuberculosis.<br />

Examination <strong>of</strong> the <strong>sputum</strong> smear is helpful and has a high <strong>positive</strong><br />

predictive value (Gordin, 1990).<br />

• Chest radiograph in pulmonary TB<br />

The chest radiograph remains the most widely used and the most<br />

valuable tool in the diagnosis <strong>of</strong> pulmonary TB. Radiographic findings<br />

accurately reflect the pathologic process that occurs in the development <strong>of</strong><br />

primary and reactivation TB (try TB traditionally been a disease <strong>of</strong>infants<br />

and children) (Bloch et aI., 1989).<br />

In patients who have signs and <strong>symptoms</strong> suggesting pulmonary TB<br />

standard posterior-anterior and lateral radiograph <strong>of</strong> the chest should be<br />

obtained. Apical, lordotic or oblique views may aid in visualizing lesions<br />

obscured by bony structures and the heart. Bronchography may be useful in<br />

the definition <strong>of</strong> bronchial stenosis or bronchiactasis (Bass et aI., 1990).<br />

The traditional appearance <strong>of</strong>reactivation TB in the chest is a focal<br />

infiltrate and/or cavity in the apical or posterior segment <strong>of</strong>an upper lobe<br />

or perhaps in the superior segment <strong>of</strong>a lower lobe. While these traditional<br />

concepts <strong>of</strong> TB are still valid, a significant change in the pattern <strong>of</strong><br />

pulmonary TB has occurred in the past 30 years, with a much greater<br />

incidence <strong>of</strong> primary TB in adults. This change was first pointed out in<br />

1977, that noted a high incidence <strong>of</strong> nontraditional radiographic finding in<br />

adults with TB (Khan et aI., 1977). These non traditional findings reflected<br />

44


A<br />

I High resolution computed tomography (HRCT)<br />

I<br />

-<br />

-. . 1<br />

I<br />

1<br />

I<br />

I<br />

"A'<br />

a<br />

HRCT, The terms used to interpret HRCT findings in the active cases by<br />

Hatipoglu et al., (1996)<br />

1) Centrilobular nodule or linear structures : Well defined lesions 1-4 mm<br />

thick, separated by more than 2mm from the pleural surface or<br />

interlobular septa.<br />

2) " Tree in bud " appearance : A branching linear structure with more<br />

than one contiguous branching site.<br />

3) Macronodule : A nodule 5-8 mm in diameter<br />

In addition ,consolidation (lobular ,subsegmental ,segmental ,lobar )<br />

bronchial wall thickening, cavitation (single, multiple), emphysema ,<br />

bronchovascular distortion, fibrotic changes, pleural thickening,<br />

bronchiectasis, lymphadenopathy, parenchymal calcification pleural<br />

effusion, ~niliary nodules, and ground glass appearances were noted.<br />

Skin tests<br />

I a- Tuberculin test:-<br />

Tuberculin skin test is the standard method for identifying persons<br />

infected with M. tuberculosis. (ATSICDC, 1990).<br />

Sensitivity, specificity and <strong>positive</strong> predictive value <strong>of</strong> the tuberculin<br />

1 skin test (Blach, 1998). Although the tuberculin skin test is now the only<br />

method for detecting M. tuberculusis infection, the test is neither 100<br />

percent sensitive nor 100 percent specific. Sensitivity is a test's ability to<br />

correctly identify persons who have a condition (e.g Those infected with.


An induration <strong>of</strong> 2 1Omm is classified as <strong>positive</strong> in all persons who<br />

do not meet any <strong>of</strong> the above criteria but who belong to one is more <strong>of</strong> the<br />

following groups having high risk for TB. Injected-dmg users know to be<br />

HIV seronegative persons who have other medical conditions that have<br />

been reported to increase the risk for progressing from latent TB infection<br />

to active TB, including diabetes mellitus, conditions requiring prolonged<br />

high-dose corticosteroid therapy and other immunosuppressive therapy<br />

(including bone marrow and organ transplantation), chronic renal failure,<br />

some hematologic disorders (e.g. leukemias and lymphomas). Other<br />

specific malignancy (e.g. carcinoma <strong>of</strong> the head or neck). Weight loss <strong>of</strong><br />

210 % below ideal body weight, silicosis, gastrectomy and jegunoileal<br />

bypass. Residents and employees <strong>of</strong> high risk. Children < 4 years <strong>of</strong> age or<br />

infants, children and adolescents exposed to adults in high-risk categories.<br />

Congegate setting: prisons, jails, nursing homes and other long-<br />

tern1 facilities for the elderly, l~ealth care facilities (including some<br />

residential mental health facilities), and homeless shelters.<br />

An induration <strong>of</strong> > 15mm is classified as <strong>positive</strong> in persons who do<br />

not meet any <strong>of</strong> the above criteria (Bloch, 1998).<br />

b- Medical research council test:<br />

A new diagnostic test for TB has been described that can be done as<br />

two skin tests, or from blood samples based on the reaction to 38.A and<br />

38.G peptide <strong>of</strong> 38 kDa. Reaction to peptide 38.A identifies people who<br />

have had BCG vaccination or previous TB, or those who have active TB.<br />

Reaction to 38.G identifies people the first two <strong>of</strong> these categories but not<br />

the third, as people with active TB lose the T-cell response to it. Thus, the


!fffwwoj"£iterature<br />

smaller volumes. Quality and quantity <strong>of</strong> <strong>sputum</strong> specimens were assessed<br />

independently. The likelihood <strong>of</strong> a <strong>positive</strong> smear is increased three-folds,<br />

and that <strong>of</strong> a culture two folds when <strong>sputum</strong> quality is good, irrespective <strong>of</strong><br />

<strong>sputum</strong> quantity. In specimens <strong>of</strong> sufficient quantity, both smear and<br />

culture positivity are doubled when compared to specimens with a volume<br />

<strong>of</strong> less than 3m!. More than 80 % <strong>of</strong> <strong>positive</strong> smears and cultures are<br />

originated from specimens <strong>of</strong> good quality and <strong>of</strong> sufficient quantity.<br />

Macroscopical evaluation <strong>of</strong> <strong>sputum</strong> specimens contributes to optimizing<br />

laboratory diagnosis, and may have a financial impact on the cost involved<br />

in the diagnosis <strong>of</strong>pulmonary TB (Weyer, 1990 and kramer et aI., 1990).<br />

2) Sputum induction:<br />

There are several methods for obtaining <strong>sputum</strong> from the cooperative<br />

patients with non productive cough. One <strong>of</strong>these methods is the inhalation<br />

<strong>of</strong> warm, aerosolized hypertonic (5 % -10 % ) saline which irritates the<br />

lungs enough to induce both coughing and the production <strong>of</strong>a thin, watery<br />

specimen. After induction, patient may cough and produce additional good­<br />

quality specimens, which should also be submitted to the laboratory (ATS,<br />

1990). It has been concluded that in addition to obtaining <strong>sputum</strong> from<br />

patients who are unable to expectorate, <strong>sputum</strong> induction may have a useful<br />

role in improving the care detection rate <strong>of</strong>smear <strong>positive</strong> pulmonary TB,<br />

particularly in areas where facilities for more invasive and expensive<br />

techniques such as fibreoptic bronchoscopy are not available (Parry et aI.,<br />

1995).<br />

3) Bronchoscopic specimens:<br />

When neubulization is ineffective or an immediate diagnosis is<br />

needed bronchoscopy is the next best choice because this procedure<br />

51


provides additional material for study (Washings, bmshings, and biopsy<br />

specimens) and can help one obtain rapid diagnosis <strong>of</strong> tuberculosis (Zheng<br />

and Roberts, 1999).<br />

Wallace et al. (1981), found that in 41 patients proved to have TB,<br />

cultures <strong>of</strong> specimens, taken during fiberoptic bronchoscopy, were <strong>positive</strong><br />

in 39 cases. The post-bronchoscopy <strong>sputum</strong> was the most helpfull specimen<br />

in the diagnosis <strong>of</strong> pulmonary tuberculosis in patients with repeated<br />

negative <strong>sputum</strong> by direct smear and in whom <strong>sputum</strong> could not be<br />

produced (Abd-El-Hakim et al., 1987). Also Osman et al,, (1995),<br />

concluded that fiberoptic bronchoscopy is a valuable diagnostic tool for<br />

pulmonary mycobacterial infection.<br />

The local anesthetics used during fiberoptic bronchoscopy may be<br />

lethal to M. tuberculosis, so specimens for culture should be obtained with<br />

a minimal amount <strong>of</strong> anesthesia. However irritation <strong>of</strong> bronchial tree during<br />

the fiberoptc bronchoscopy procedure will frequently leave the patient with<br />

productive cough. This post-bronchoscopy <strong>sputum</strong> was the only source <strong>of</strong><br />

<strong>positive</strong> inaterial in some study (Rossman and Oner- Eyuboglu, 1998).<br />

4) Gastric lavage :<br />

Gastric lavage may be necessary for children and some adult patients<br />

who are unable to expectorate <strong>sputum</strong>, gastric lavage is a specimen <strong>of</strong><br />

alternative choice, although it my not be as good as induced <strong>sputum</strong> for<br />

culturing (Pomputius et al., 1997). Some <strong>of</strong> gastric contents should be<br />

aspirated early in the morning, after the patient has fasted at least 8-10<br />

hours, and preferably while the patient is still in bed (ATS, 1990).


I _<br />

gfrww<strong>of</strong>£iterature<br />

If the stomach is empty about 20ml <strong>of</strong>sterile water is introduced<br />

slowly through the tube and withdrawn. Gastric specimens must be<br />

processed immediately since the acidity and enzyme content <strong>of</strong>the gastric<br />

juice are harmful to the mycobacteria. If transport will be delayed more<br />

than 4 hours, the specimen should be neutralized with disodium phosphate<br />

or sodium carbonate buffer salt to a pH <strong>of</strong>7.0. In children with suspected<br />

pulmonary TB, gastric lavage yielded a positivity <strong>of</strong> 81.5 % for AFB<br />

beside its satisfactory results, gastric lavage technique was well accepted<br />

by mothers and health staff, and was very cost-effective (Migliori et al.,<br />

1990).<br />

5) Laryngeal swabs:<br />

Laryngeal swabs are an alternative to gastric lavage. They are<br />

simpler to perform and less uncomfortable for the patient. The operator<br />

should be gowned and masked and the swabs taken in pairs. The first swab<br />

usually makes the patient cough and the second <strong>of</strong>ten collects the better<br />

specimen (Seaton, 1989).<br />

6) Other specimens:<br />

In a case <strong>of</strong> extrapulmonary TB, it is occasionally necessary to<br />

examme specimens other than pulmonary secretions as, urine, CSF, joint<br />

and pleural fluids, and tissue biopsy material (Kubica et al., 1989).<br />

• Processing <strong>of</strong> specimens<br />

In order to recover mycobacteria from specimens that contain large<br />

numbers <strong>of</strong> normal flora, decontamination <strong>of</strong> the specimen is needed.<br />

Mycobacteria are slow growing and have an extended generation time (20<br />

to 22 hours) compared with that <strong>of</strong>common bacterial flora (40 to 60 min),<br />

53


f<br />

2) The 2 nd role for the smear is m monitoring the patient's response to<br />

therapy, if a patient is grossly <strong>positive</strong> at the start <strong>of</strong>treatment<br />

The most commonly used technique is the Ziehl-Neelsen stain, this<br />

necessitates the use <strong>of</strong> hot carbolfuchsin followed by decolorization with<br />

acid and alcohol, and counter staining with methylene blue. The bacilli<br />

appear as red rods on a blue back ground. When large numbers <strong>of</strong>smears<br />

have to be examined staining with auramine followed by fluorescence<br />

microscopy is more rapid. However, this can give rise to false <strong>positive</strong> as a<br />

result <strong>of</strong> artifacts and it is advisable to check all <strong>positive</strong> with Ziehl­<br />

Nee1sen stain. The same slide can be over stained by the Ziehl-Neelsen<br />

technique (McNicol et ai, 1995).<br />

Procedures <strong>of</strong>acidfast staining are <strong>of</strong>two general types:<br />

• Z.N. is a hot acid-fast stain in which the fixed smears are poured with<br />

carbol-fuchsin and gently heated till the steam rises. The smears are<br />

decolourized with 25 % sulfuric acid and 95 % alcohol. After washing<br />

with water the smears are counter-stained with 0.1% methylen blue,<br />

then washed and dried for examination (Rao et al., 1982).<br />

• Kinyoun is a cold acid fast stain in which, kinyoun's carbol- fuchsin<br />

with basic fuchsin and phenol are used in concentration higher than that<br />

<strong>of</strong> Z.N. stain. Acid alcohol was employed as decolourizer, while<br />

malachite green as the counter stain (Levy et aI., 1988).<br />

Wilson et al. (1981), reported that, the fluorochrome method can be<br />

-.t 1 used to facilitate and enhance rapid examination <strong>of</strong> smears for<br />

mycobacteria. Also Bates et al. (1982), found that, in fluorescence<br />

microscopy. The number <strong>of</strong>organisms has been estimated to average 3.65<br />

56


1<br />

-I<br />

times the number seen with the Z.N.stain. Mobasher et at (1984), reported<br />

the advantages <strong>of</strong> the fluorescent microscopy as follow:<br />

a) The bright fluorescent bacilli are much more obvious owing to increased<br />

contrast against the dark background .<br />

b) The bacilli can be recognized at a lower magnification.<br />

c) The time required to search a smear effectively is much reduced.<br />

d) It is difficult or impossible with Z.N. method to detect bacilli towards<br />

r: the periphery <strong>of</strong>the field, however the fluorescence microscopy, the out<br />

-;;. J in tissue.<br />

1<br />

<strong>of</strong> focus images <strong>of</strong> the stained organisms can be detected even at the<br />

extreme edges <strong>of</strong>the field.<br />

David et aI. (1989), described nachtblau stain which stained the<br />

AFB blue. They used neutral red or pyronine as a counter-stain. They<br />

claimed that the blue bacilli against the red or yellow back ground are<br />

easier to detect. Thomas et al. (1988), used silver salts to stain the M.T.B.<br />

Toman (1979), found that false <strong>positive</strong> acid-fast smear may result<br />

from: 1) The presence <strong>of</strong>acid fast particles other than tubercle bacilli such<br />

as certain food particles like waxes and oils, saprophytic AFB like M.<br />

Kansasii or nocardia species, spores <strong>of</strong>bacillus subtilis, fibers, pollens and<br />

scratches on the slide.<br />

2) Contamination through accidental transfer <strong>of</strong>bacilli from one <strong>positive</strong><br />

+J smear to another negative one.<br />

57


1<br />

I<br />

rJ(fview o[£iterature<br />

On the other hand, false negative acid-fast smear may be due to<br />

inadequate. Collection <strong>of</strong> <strong>sputum</strong>, Storage <strong>of</strong>specimen, Preparation <strong>of</strong>the<br />

smear, Staining <strong>of</strong> slides and Examination <strong>of</strong>the smears.<br />

2) Cultivating M. TB<br />

The definitive diagnosis <strong>of</strong> mycobacterial disease demands that the<br />

causative agent be recovered on culture medium, and identified by using a<br />

number <strong>of</strong>differential in vitro tests.(Zheng and Roberts, 1999)<br />

Kent and Kubica, (1985), defined The ideal medium for isolation <strong>of</strong><br />

mycobacterial should:<br />

I) Support rapid and luxuriant growth <strong>of</strong> small numbers <strong>of</strong>mycobacteria<br />

2) Permit preliminary differentiation <strong>of</strong> isolates on the basis <strong>of</strong>pigment<br />

production and colony morphology.<br />

3) Inhibit the growth <strong>of</strong>contaminants.<br />

4) Be economical and simple to prepare from readily available ingredients<br />

and<br />

5) Enable the performance <strong>of</strong> drug susceptibility tests<br />

Many different media are available for cultivating mycobacteria, most<br />

are variations <strong>of</strong> either egg-potato base (Lowenstein-Jensen Medium and<br />

American Thoracic Society Medium) or serum agar base (Middle Brook<br />

7HIO and 7HII) media. Each medium has advantages and disadvantages,<br />

,.f.l and they compliment each other, the advantages <strong>of</strong>egg media as L.T media<br />

are that, they can be stored in refrigerator for several months, less likely to<br />

become contaminated during preparation, and also yield a greater number<br />

58


•r<br />

?f(ww<strong>of</strong>Literature<br />

The major drawbacks <strong>of</strong> the BACTEC system are the use <strong>of</strong><br />

radioactive substrates and the necessity <strong>of</strong>specialized instrumentation. It<br />

has also suffered from problems with needle-heater defects, leading to<br />

cross mycobacteria <strong>of</strong>bottles (Murray, 1991).<br />

A more recent addition to the culture alternatives has been the<br />

adaptation <strong>of</strong> the septi-chek system for mycobacteriology. This system<br />

employs a middle brook broth based system with a paddle that has<br />

chocolate agar, middle brook agar, and an egg-based medium similar to L.J<br />

agar. Several studies have demonstrated the recovery in this system to be<br />

comparable or superior to that with BACTEC, and better than that with a<br />

conventional medium. It can also, be combined with an additional medium<br />

to increase overall recovery. The speed <strong>of</strong>recovery does not appear to be as<br />

fast with the BACTEC system, but it is faster than with conventional<br />

media. This system does not use radioactive substrates and requires no<br />

instrumentation (Whittier et aI., 1992).<br />

3) Animal inoculation<br />

With the more refined culture methods available today, and with the<br />

processing <strong>of</strong> multiple specimens from the same patient, it is not necessary<br />

to resort to animal inoculation. However, in few rare instances, guinea pig<br />

inoculation may be used when (ATS, 1990) :-<br />

A) Specimens are consistently contaminated on culture.<br />

b) Specimens are <strong>positive</strong> on microscopy but repeatedly negative on culture<br />

or<br />

c) Specimens are aseptically collected where organisms may be few in<br />

number, and every attempt is made to establish the diagnosis.<br />

61


j -<br />

Immunological techniques in the diagnosis <strong>of</strong> mycobacterial<br />

infection<br />

Engvall and Perlman (1972), were the first who described the<br />

ELISA, they reported that it is very sensitive and simple method for<br />

detection and measurement <strong>of</strong> antibodies in sera. Nassau et aI. (1976),<br />

used ELISA for diagnosis <strong>of</strong> tuberculosis using concentrated culture filtrate<br />

<strong>of</strong> M.TB using concentrated as antigen. They found that 84% <strong>of</strong> <strong>sputum</strong><br />

<strong>positive</strong> cases were <strong>positive</strong> by that test and only 8% false <strong>positive</strong><br />

reactions were observed. They also concluded that serum dilution <strong>of</strong> I: 100<br />

gave good discrimination between sera from tuberculous patients and<br />

controls. They reported that ELISA proved to be satisfactory for detection<br />

<strong>of</strong> antimycobacterial antibodies. They postulated that the use <strong>of</strong> specific<br />

antigen should increase the specificity <strong>of</strong>the test.<br />

The major limiting factor in the serodiagnosis <strong>of</strong> tuberculosis is that<br />

no single species specific antigen <strong>of</strong> mycobacterium tuberculosis has been<br />

shown to be significantly elevated in all cases <strong>of</strong>active tuberculosis. On the<br />

contrary, most <strong>of</strong>the antibody response in tuberculosis is directed towards<br />

those antigens common to all mycobacteria and, to some extent, present in<br />

other genera. Sensitive assays show that virtually all individuals have such<br />

antibodies (Grange et aI., 1980). In spite <strong>of</strong> that many research<br />

laboratories have demonstrated that ELISA measurement <strong>of</strong>IgG antibody<br />

to mycobacterial antigen can be used for the serologic diagnosis <strong>of</strong><br />

tuberculosis (Shim et aI., 1989).<br />

Other serodiagnostic techniques including radio-immunoassay (RIA)<br />

and inhibition <strong>of</strong> monoclonal antibodies, had less extensive studies but<br />

appear promising (ATS, 1990).<br />

62


Cigarette smokers were categorized into 3 groups. Mild, moderate,<br />

and heavy smokers, according to the number <strong>of</strong>pack years (Miller et<br />

at, 1982) Mild < 20 pack years. Moderate 20-49 pack years and<br />

heavy >49 pack years) where pack years calculated as follow:<br />

Pack year = No <strong>of</strong>cig! day X duration in years<br />

b- History <strong>of</strong>present illness:<br />

Including general and <strong>respiratory</strong> <strong>symptoms</strong> (cough, expectoration,<br />

r chest pain, dyspnea and chest wheezes) (Mobasher, 1993). Leitch (2000),<br />

20<br />

suspected plumonary tuberculosis on clinical grounds when (persistent<br />

cough with or without <strong>sputum</strong>, haemoptysis, general malaise, weight loss,<br />

and recurrent colds and <strong>symptoms</strong> free discovered on routine radiograph)<br />

were present. Weight loss was defined as greater than 4.5kg or 10% <strong>of</strong><br />

ideal body weight within last 6 months (Cohen et at, 1996). Dyspnea was<br />

classified from (grade 0) to (grade III) by Mobasher (1993).<br />

(1) Grade 0 : dyspnea on extraordinary effort.<br />

(2) Grade I : dyspnea on ordinary effort.<br />

(3) Grade II : dyspnea on slight effort.<br />

(4) Grade III : dyspnea at rest.<br />

Some <strong>symptoms</strong> were stressed upon chest pain were asked about the<br />

nature and site. Hamoptysis was classified into degrees by Muren, (1982),<br />

and Mobasher (1993): mild, moderate and severe.<br />

"'Mild = occasionally blood - streaked <strong>sputum</strong>,<br />

'" Moderate = persistent blood streaked <strong>sputum</strong> and frank blood,<br />

69


"'Sever or massive = coughing up 150 cc more at once, 400 mIl or more <strong>of</strong><br />

.. - blood within 3 home or 600 ml <strong>of</strong> blood within 24 hours<br />

.J<br />

r--<br />

(c) Past history:<br />

Past history <strong>of</strong> medical importance were asked for stressing the<br />

importance <strong>of</strong>predisposing factor for TB e.g D.M. and past history <strong>of</strong>treatment<br />

<strong>of</strong>corticosteriod and other immunosuppressive therapy (ATS, 1990).<br />

Past history suggestive <strong>of</strong> TB diseases e.g. : acquired hip joint<br />

disease leading to limping, sinus, recurrent ischiorectal abscesses, port's <strong>of</strong><br />

spine, contact to known TB-case and pervious thoracithesis or<br />

lymphadenopathy (Mobasher, 1993).<br />

(2) Full clinical examination: -<br />

General and local examination with special concern about facial<br />

appearance toxic face or pallor and body built and scar <strong>of</strong>BCG.<br />

Local chest signs as post-tussive rales and bronchial breathing as<br />

these are the principle finding <strong>of</strong>tuberculosis specially in the apeces <strong>of</strong> the<br />

lungs (Rossman and Mayock, 1995).<br />

(3) Radiological examination:<br />

A)Plain CXR:<br />

Postero-anterior view <strong>of</strong>full-sized ordinary CXR were done to show<br />

the radiographic features suggestive <strong>of</strong>pulmonary T B, opacities mainly in<br />

the upper zones, patchy or nodular opacities, presence <strong>of</strong>cavity or cavities,<br />

presence <strong>of</strong> calcification, bilateral opacities especially if in upper zone(s)<br />

and opacities that persist after several weeks (and thus are less likely due to<br />

70


acute pneumonia (Leitch, 2000). The National TB Association <strong>of</strong> the<br />

USA (1961), classified radiographic features into three groups:<br />

(1) Minimal:<br />

Lesions <strong>of</strong> slight to moderate density, with no demonstrable<br />

cavitation. They may involve a small port <strong>of</strong> one or both lungs, but the total<br />

extent, regard less <strong>of</strong>distribution, should not exceed the volume <strong>of</strong> lung on<br />

one side that occupies the space above the second chondrosternal junction<br />

and the spine <strong>of</strong> the fourth or the body <strong>of</strong>the fifth thoracic vertebra.<br />

(2) Moderately advanced:<br />

Lesions may be present III one or both lungs, but the total extent<br />

should not exceed the following limits disseminated lesion <strong>of</strong> slight to<br />

moderate density that may extend throughout the total volume <strong>of</strong>one lung<br />

or the equivalent in both lungs; dense and confluent lesions limited in<br />

extent to one-third the volume <strong>of</strong> one lung; total diameter <strong>of</strong> cavitation, if<br />

present, must be less than 4 em.<br />

(3) Far advanced:<br />

B) CT.<br />

Lesions more extensive than moderately advanced.<br />

C.T. was done to exclude other possible associating agents e.g<br />

tumour, 15 patient did C.T to exclusion <strong>of</strong> malignancy and after<br />

microbiological examination, there were 12 active TB. smear +ve and 3<br />

cases were smear -ve.<br />

71


-. -I<br />

(4) Tuberculin skin test:<br />

Tuberculin test was done to support the establishment <strong>of</strong> diagnosis in<br />

cases with negative smear. It was performed by injecting 5 tuberculin units<br />

(Tu) in O.lml <strong>of</strong> PPD intradermally (Mantoux technique) in the volar<br />

aspect <strong>of</strong> the left forearm. Special 1 ml disposable syringes graduated in<br />

hundredth <strong>of</strong> milliliters were used with 26 gauge 10 mm needles <strong>of</strong> short<br />

bevel. A separate sterile syringe and needle were used for each person<br />

tested. A little more than 0.1 <strong>of</strong> tuberculin was then removed and the<br />

volume subsequently adjusted to exactly 0.1 ml by ejecting the extra<br />

solution, and then slowly ejected. The injection to be valid-should raise a<br />

flat, anearnic wheal with pronounced pits and a steep borderline. The test<br />

was read after 48 and/or 72 hours. The reading was limited to a single<br />

aspect <strong>of</strong>the reaction, the induration. The site was carefully palpated and if<br />

an induration was present, its limits were deter mined and its largest<br />

transverse diameter was measured in millimeters by using s<strong>of</strong>t flexible<br />

transparent roller calibrated in millimeters. Positive tuberculin test was<br />

indicated if the indurated area was 10 mm or more (ATS, 1990 and<br />

Arnadottir et al., 1996).<br />

(5) Routine investigations:<br />

Complete blood picture (to detect any heamatologic disorders as Hb,<br />

and lymphocytic percentage). Erythorcyte sedimentation rate (ESR) as its<br />

elevation is compatible with tuberculosis, post prandial blood sugar (for<br />

detection <strong>of</strong>diabetic risk) (Rossman and Mayock, 1995).<br />

72


,"--- -<br />

(6) Mycobacterial investigations:<br />

These were done in the mycobacteriology laboratory, Microbiology<br />

and Immunology Department Faculty <strong>of</strong> Medicine Zagazig University.<br />

A-Samples:<br />

Sputum collection: The patients were given clean plastic containers<br />

and instructed to give morning <strong>sputum</strong> after deep coughing into the<br />

containers. The sputa were transported without delay to the laboratory.<br />

Three successive <strong>sputum</strong> samples were collected for each negative cases.<br />

In patients who did not produce <strong>sputum</strong>, the specimens were induced<br />

<strong>sputum</strong> samples taken with an air- powered neublizer with 0.45% Nacl<br />

solution for 15 minutes (Cohen et al., 1996).<br />

If induced <strong>sputum</strong> was failed or a mount was unfit for diagnosis and<br />

so fiberoptic bronchoscop was done and this occurred for 15 patients<br />

bronchoscopic lavage was taken and BAL was sent for laboratory.<br />

(Funahashia et aI., 1983).<br />

All previous specimens were subjected to direct Kinyoun's staining<br />

after decontamination and concentration.<br />

B- Specimen processing: (Digestion decontamination method) (Ratnan<br />

• Reagent and equipment.<br />

- Sodium hydroxide 5% solution<br />

't-- - Nsacetyl L. cystein (NALC)<br />

- Phosphate buffer (pH = 6.8)<br />

- A plastic centrifuge tube (50 ml)<br />

and Marchy,1988).<br />

73


- Centrifuge.<br />

- Vortex Mixer.<br />

- Phenol can<br />

- Electric slide warmer<br />

• Procedure<br />

A morning <strong>sputum</strong> sample or bronchial lavage was transferred to 50<br />

ml plastic centrifuge tube, and an equal volume <strong>of</strong>NALC-NaOH solution<br />

was added and mixed well. The tube was allowed to stand for 15-18<br />

minutes (not more than 20 minutes) at room temperature for<br />

decontamination. Then, the sample was diluted to a 50 ml volume with a<br />

sterile 0.067 M phosphate buffer saline (PBS), pH 6.8 to neutralize NaOH<br />

and centrifuged at 2800 rpm at room temperature for 15 minutes. The<br />

supernatant was poured <strong>of</strong>f into a beaker containing 10% phenol, whereas<br />

the deposit was resuspended in 2 ml <strong>of</strong> a sterile 0.2% bovine serum<br />

albumin (BSA) in physiological saline (pH 6.8), then spread on the middle<br />

2/3 <strong>of</strong> glass slide, after drying the slide on electric slide warmer at 65 C for<br />

2 minutes (Ratnan and Marchy,1988).<br />

c- Kinyoun '8 staining technique: It's modified Z. N (cold method) in<br />

which:<br />

1- high concentration <strong>of</strong>carbol fuchisin .<br />

2- devoid <strong>of</strong> direct heat which has lethal effect <strong>of</strong>TB bacilli,<br />

3- The concentration <strong>of</strong> specimen by centrifugation conducted in this<br />

method increase the capacity to detect mycobacteria (Saceanu et al.,<br />

1993 and Fodor, 1995).<br />

74


Name:<br />

Sex:<br />

Residence:<br />

Smoking:<br />

Duration:<br />

Passive:<br />

Current smoker:<br />

Other diseases (known diagnosis) :<br />

Local<br />

1- Cough<br />

2- Expectoration<br />

3- Haernoptysis<br />

Dry<br />

Productive<br />

Duration<br />

Periodicity<br />

Sheet <strong>of</strong>TB<br />

Personal history<br />

Night<br />

Day<br />

C/O<br />

Age:<br />

Mari tal state :<br />

Occupation:<br />

Type :<br />

Degree <strong>of</strong> smoking:<br />

Ex. Smoker:<br />

Other:<br />

Amount<br />

Colour<br />

Odour<br />

Aspect<br />

Duration <strong>of</strong> expectoration<br />

Mild<br />

Moderate<br />

Severe<br />

Number <strong>of</strong>attacks<br />

Duration<br />

79


J..<br />

r<br />

RESULTS


i<br />

r-<br />

value 92.80/0. Tuberculin test sensitivity was 75.3 and specificity was 50%<br />

+ve predictive value was 87.9%.<br />

Table (17) shows that, specificity and +ve predictive value was<br />

improved when measured for combined <strong>symptoms</strong> and CXR and tuberculin<br />

test as for (Cough + expectation and weight loss) combined specificity was<br />

78.1% and +ve predictive value <strong>of</strong>90.6% and when combined with typical<br />

CXR was 90.6%, 94% respectively while combined manifestations that<br />

only presented in smear +ve cases had a specificity, sensitivity, negative<br />

and <strong>positive</strong> predictive value <strong>of</strong> 100%, 7.8%, 18.4%. and 100%.<br />

Tables (18, 19) show that, <strong>symptoms</strong> presentation <strong>among</strong> smear +ve<br />

cases for AFB with special references to age group < 20y, 20-40y and> 40<br />

there were non significantly difference in cough, chest pain, fever and<br />

weight loss and another were significantly higher in > 40y as in chest<br />

wheeze, dyspnea and night sweats and anorexia P < 0.05 and expectoration<br />

was significantly higher in age group 20-40y and lower in < 20y (58.3%),<br />

p= 0.0001


1 r--<br />

.....-­<br />

..., I<br />

p= 0.0002, shortest mean duration was haemoptysis = 1.3m ± 0.71 and<br />

longest chest wheezes 13.97 M ± 15.9 in smear +ve for AFB.<br />

(Table 22), show that mean duration <strong>of</strong> general <strong>symptoms</strong> <strong>among</strong><br />

smear +ve and smear -ve cases for AFB there was highly significant<br />

difference as regard duration <strong>of</strong>fever p= 0.001, shortest mean duration was<br />

fever = 1.38 M ± 0.55 M and longest was anorexia 2.8 M ± 1.6 M in smear<br />

+ve for AFB versus 2.05 M ± 1.8 M and 2.1 M ± l,SM in smear -ve cases<br />

for AFB respectively.<br />

(Table 23) shows that, III smear +ve cases for AFB duration <strong>of</strong><br />

<strong>respiratory</strong> <strong>symptoms</strong> as percentage presentation per month before<br />

diagnosis, chest pain and haemoptysis seeked medical advise through 1s<br />

month were 69.8%, 70% respectively. While the <strong>symptoms</strong> (Cough<br />

expectoration and dyspnea) mostly represented in 1-3 months with high<br />

percentage. 42.7%,43.3%,36.4% respectively but<br />

Table (24) shows that, in smear +ve cases for AFB duration <strong>of</strong>non<br />

<strong>respiratory</strong> <strong>symptoms</strong> fever, night sweating, weight loss and anorexia, no<br />

any patients presented beyond more than 6M and fever night sweats<br />

represented early through 1st month 64.5%, 56.50/0 and weight loss and<br />

anorexia 1-3 month 55% and 54.8% respectively.<br />

Table (25) shows, a high significant difference <strong>of</strong> typical CXR<br />

presentation in smear +ve 83.7% than smear -ve 59.4 % for AFB P = 0.006<br />

far advanced lesion was significantly higher in smear +ve 48.1 % for AFB<br />

than in smear -ve 25% for AFB, P = 0.001 and mild lesions was<br />

statistically significant in smear -ve than in smear +ve, P = 0.03.<br />

84


Table (26) shows that, there was high significant difference between<br />

" smokers with typical CXR in smear +ve than in smear -ve for AFB, P=<br />

0.001, <strong>among</strong> smear + for AFB typical CXR smoker 85.5% and in smoker<br />

81.4% but there is a high difference between typical and atypical in smoker<br />

smear +ve patients 85.5% and 14.5% respectively, and also there was non<br />

significance in smear -ve for AFB p> 0.05 typical smoker CXR in smear­<br />

ve 60% and non smoker 59.1% and there is no significance increase in<br />

smoker smear -ve as regard typical and atypical presentation 60%, 40% in<br />

smear +ve smoker for advanced = 47.7% and 30% in smear -ve for AFB.<br />

L<br />

1"-- Minimal lesions in smear +ve 20%, 50% in smear -ve for AFB.<br />

. "<<br />

Table (27) showed <strong>positive</strong> significant correlation between smoking<br />

degree and CXR extent r = 0.43, P < 0.05.<br />

Tables (28, 29) show that, <strong>positive</strong> significant correlation between<br />

haemoptysis and CXR extent r = 0.49 P = 0.001 and also, there was<br />

significant association between haemoptysis and CXR (Cavitation and<br />

extent), cavitary haemoptysis in smear +ve represent 66.3% and in smear-<br />

ve for AFB 15.4%, P = 0.001.<br />

Table (30) shows that, CT findings in smear +ve and smear -ve for<br />

AFB were non significant P > 0.05 in smear -ve for AFB nodular single<br />

cavity, multiple small cavities and pleural effusion was 0% and represents<br />

33%, 33%, 16.5% and 25% in smear +ve for AFB. Calcified nodule was<br />

16.75% in smear +ve and 66% in smear -ve and consolidation was 41.7%<br />

in smear +ve and 33% in smear -Yeo<br />

Table (31) shows that, correlation between CT and X- ray finding it<br />

was non significant P > 0.05. Consolidation 40%, calcification and single<br />

cavity represented in both CXR + CT by 26.7% bronchial dilation not<br />

85


\ P = 0.001 mean number <strong>of</strong> 1 st hours (67.5 ± 29.2) mm in smear +ve cases<br />

-<br />

J<br />

I<br />

d<br />

2 11<br />

J r'--<br />

I<br />

hours (107.6 ± 34.4) mm and lymphocyte percentage also were<br />

significantly higher in smear +ve for APB P = 0.03 and mean percentage<br />

(28.8% ± 11.750/0).<br />

Table (39) showed a negative significant correlation between ESR<br />

and Hb content, r = - 0.22, P < 0.01.<br />

87


2 -?=,!<br />

---<br />

M>.i!ll . - -.*-r-.*,y-- . 1<br />

- -.<br />

u:,:-,* G*-+&L-, --<br />

. i<br />

+- ..VX .-<br />

-- -- - - - A:,: ;'<br />

\ .,, -dLx, . - I 1<br />

\, !:T-&% hi


1<br />

(6) Prevalence <strong>of</strong> cough <strong>among</strong> smear +ve and smear -ve case for AFB<br />

Subject Smear +ve for AFH Smear -ve for AFB Xl P<br />

Symptom No = 154 0/0 No =32 %<br />

Cough (with) 150 97.4 20 62.5 41.05 O.OOIHS<br />

Without 4 2.6 12 37.5<br />

(7) Prevalence <strong>of</strong> expectoration <strong>among</strong> smear +ve and smear -ve cases<br />

for AFB.<br />

Subject Smear +ve for AFB Smear -ve for AFB Xl P<br />

Res. Symptom No % No %<br />

Expectoration with 134 87.0 16 50 23.25 O.OOOlHS<br />

Without 20 13.0 16 50<br />

(8) Prevalence <strong>of</strong> dyspnea <strong>among</strong> smear +ve and smear -ve cases for<br />

AFB with special reference to its grade.<br />

Dyspnea I II III Xl P<br />

Smear +ve No: 77 46 31 0<br />

Percentage<br />

50% 59.7 40.3 0.0 0.054<br />

5.84<br />

Smear -ve No: 15 10 4 1<br />

Percentage<br />

48% 66.7 26.7 6.7<br />

l)()


(12) Prevalence <strong>of</strong> non <strong>respiratory</strong> <strong>symptoms</strong> <strong>among</strong> smear +ve and<br />

smear -ve cases for AFB.<br />

Subject Smear +ve for AFH Smear -ve for AFB X 2<br />

Symptoms No % No %<br />

Fever with 93 60.4 17 53.1 0.58 0.44<br />

Without 61 39.6 15 46.9<br />

Night sweating with 62 40.3 13 40.6 0.0 0.97<br />

Without<br />

92 59.7 19 59.4<br />

Weight loss with 80 51.9 10 31.4 3.27 0.04 S<br />

Without<br />

74 48.1 22 68.6<br />

Anorexia with 42 27.3 8 25.0 0.07 0.79<br />

Without 112 72.7 24 75.0<br />

l)J<br />

P


'd<br />

1<br />

re,<br />

4<br />

S<br />

re,<br />

V1<br />

u<br />

-.<br />

6<br />

0<br />

s<br />

W<br />

B<br />

CD<br />

s<br />

7<br />

+<br />

*C<br />

re,


.iIi-'· . (13) Distribution <strong>of</strong> combined clinical <strong>symptoms</strong> (Cough, expectoration<br />

and weight loss) <strong>among</strong> smear +ve and smear -ve cases for AFB.<br />

Smear +ve for AFB Smear -ve for AFB X 2<br />

Comb clinical No(154) % No(32) % 5.47 0.019S.<br />

with 68 44.2 7 23%<br />

without 86 55.8 25 77%<br />

(14) Distribution <strong>of</strong> combined clinical manifestation (Cough,<br />

expectoration and weight loss) plus typical CXR presentation in<br />

smear +ve and smear -ve cases for AFB.<br />

Combined clinical Smear +ve for AFB Smear -ve for AFB X 2<br />

+ typical CXR<br />

NO 0/0 NO 0/0<br />

Yes 47 30.5 3 9.8% 6.03<br />

No 107 69.5% 29 91.2%<br />

P<br />

P<br />

0.014<br />

(IS) Comparison between smear +ve and smear -ve cases for AFB as<br />

regard presence <strong>of</strong> combined manifestations ( Cough, Haemptysis,<br />

dyspnea, fever, loss <strong>of</strong> weight, typical CXR presentation and +ve<br />

tuberculin skin test).<br />

Smear +ve for AFB Smear -ve for AFB X 2<br />

No % No %<br />

Yes 12 7.8% 0 0% 2.67 0.1 NS<br />

No 142 92.2% 32 100%<br />

95<br />

S<br />

P


Expectoration<br />

Chest pain<br />

Haemoptysis<br />

Dyspnea<br />

Night sweats<br />

,,- --<br />

Fever ,<br />

.-?A:<br />

Anorexia I<br />

.......<br />

X<br />

>


(17) Specificity and sensitivity <strong>of</strong> combined <strong>symptoms</strong> plus CXR and<br />

tuberclin skin test <strong>among</strong> smear +ve cases for AFB.<br />

Combined <strong>symptoms</strong> Sensitivity Specificity +ve predictive value -ve predictive value<br />

Cough, expectration and weight loss 44.2 78.1 90.6% 22.5<br />

Previous <strong>symptoms</strong> and typical CXR 30.5 90.6% 94 21.3%<br />

Cough, haemptysis, dyspnea, weight 7.8 100 100 18.4<br />

loss, fever, typical CXR and <strong>positive</strong><br />

tuberculin


i<br />

I*... [.;'!I<br />

7 $,'<br />

\... ..y,.<br />

< , . 1<br />

>- .-


....' ."<br />

T-<br />

I<br />

(23) Duration <strong>of</strong> <strong>respiratory</strong> <strong>symptoms</strong> <strong>among</strong> smear +ve cases for<br />

AFB.<br />

s 1M s3M s6M s 12M ;:::IY<br />

No 150 41 64 24 9 12<br />

Cough 97.4% 27.5 42.7 16.0 6,0 8.1<br />

Expect No 134 31 58 23 9 13<br />

87% 23.1 43.3 17.2 6,8 9.8<br />

Haemptysis No 80 56 23 1 0 0<br />

53% 70.0 28,8 1.3 0.0 0.0<br />

Chest No 45 7 12 6 0 20<br />

wheeze<br />

29.2% 15.6 26.7 13.3 0,0 44.4<br />

Chest pain No 53 37 12 2 1 1<br />

34.4% 69.8 22.6 3.8 1.1 1.9<br />

Dyspnea No 77 26 28 6 7 10<br />

50% 338 36.4 7.8 9.1 13.0<br />

103


'·'--1<br />

38) Mean ± SD <strong>of</strong> laboratory investigations <strong>among</strong> smear +ve and<br />

smear -ve cases for AFB.<br />

Smear +ve for AFB Smear -ve for AFB t P<br />

Mean SD Mean SD<br />

lsth 67.5 29.2 37.9 19.1 5.48 0.001<br />

ESR 2ndh 1076 34.4 682 26.5 6.1 0.001<br />

HB G/dl 10.6 19 11.0 2.04 1.14 0.25<br />

WBC XIOJ/mm 7.6 3.6 86 3.8 1.14 0.14<br />

'-_.<br />

Lymphyt % 288 II 75 24.0 10.7 2.12 0.03 sig.<br />

.'--<br />

39) Correlation between ESR (mm) and haemoglobin (gm/dL).<br />

r P<br />

ESR versus haemoglobin -0.22


--- I<br />

.---<br />

120<br />

100 •<br />

• •<br />

- • • •<br />

80 •• • •<br />

60 • • i. ..<br />

40 •<br />

20 • •<br />

• ...<br />

0 r---- .....,._--- -----------r- ----,----- ··_---1---- •<br />

----1<br />

0 2 4 6 8 10 12 14 16<br />

Fig. (7) : Correlation between HB (g/dl) and ESR (mm).<br />

112


DISCUSSION


person with cough, chest pain for one month or more, or blood spitting at<br />

any time confined to home for one month or more on account <strong>of</strong> illness.<br />

Teklu (1993) has used the definition <strong>of</strong>tuberculosis "suspect" as patient<br />

with: 1- Cough and haemoptysis for 2 weeks.<br />

2- Cough and any other <strong>respiratory</strong> <strong>symptoms</strong> with constitutional<br />

<strong>symptoms</strong> in any combination (Fever, night sweets, poor appetite,<br />

weight loss and weakness) for 4 weeks.<br />

Cohen et al (1996) found a significant correlation between<br />

<strong>symptoms</strong> "cough, <strong>sputum</strong> and weight loss" and "smear <strong>positive</strong> TB". Also<br />

they found that, the presence <strong>of</strong>cough, <strong>sputum</strong> and weight loss for less than<br />

2 weeks and the absence <strong>of</strong>typicalCXR were strong negative predictors <strong>of</strong><br />

tuberculosis. So this study was done for assessment <strong>of</strong> specificity and<br />

sensitivity <strong>of</strong> <strong>respiratory</strong> <strong>symptoms</strong> in diagnosis <strong>of</strong> active <strong>sputum</strong> <strong>positive</strong><br />

pulmonary tuberculosis.<br />

The method used In this study was microscopic examination <strong>of</strong><br />

<strong>sputum</strong> for AFB (acid fast bacilli), using kinyouns staining, concentration <strong>of</strong><br />

specimens by centrifugation conducted in this method increase the capacity to<br />

detect mycobacteria (Saceanu et aI., 1993 and Fodor, 1995) and also it has<br />

advantages <strong>of</strong>devoid <strong>of</strong>direct heat which has lethal effect on tubercle bacilli,<br />

and it has a higher significant in recovery <strong>of</strong>mycobacteria in comparison with<br />

directed ZN method (Refaat, 1999). CDC (1996) stressed the importance <strong>of</strong><br />

direct smear +ve <strong>sputum</strong> in infection. It have many advantages as it is the<br />

easiest and quickest procedure to be performed, and it provides the physician<br />

with confirmation <strong>of</strong> the diagnosis, also because it gives a quantitative<br />

estimation <strong>of</strong> the number <strong>of</strong> bacilli being excreted, the smear is <strong>of</strong> vital<br />

114


»----/<br />

J r><br />

1<br />

....-'<br />

-e,<br />

In this study (Table 20), there were significant association between<br />

smoking and some <strong>symptoms</strong> either in smear +ve or in smear -ve cases for<br />

AFB. In smear +ve cases smokers statistical significant difference was<br />

found than non smokers, as regard expectoration, dyspnea, weight loss, and<br />

chest wheezes, and in cases <strong>of</strong> smear -ve for APB significant higher<br />

association was present in cough, expectoration and chest wheezes than<br />

smear -ve non smokers. Other <strong>symptoms</strong> showed non significant<br />

differences. It was reported by Alcaid et al. (1996) that, smokers routinely<br />

present with <strong>respiratory</strong> <strong>symptoms</strong>, simulating that produced by TB,<br />

namely prolonged cough, expectoration, dyspnea, anorexia and weight loss.<br />

So this explains why dyspnea, weight loss and expectation were<br />

significantly associated with smoking in tuberculous patients.<br />

Table (2 J) elucidates the mean duration <strong>of</strong><strong>respiratory</strong> <strong>symptoms</strong>,<br />

mean duration <strong>of</strong> haemoptysis showed statistically significant difference<br />

between smear +ve and smear -ve cases for APB. The lowest mean<br />

duration was for haemoptysis (1.3 month) followed by chest pain (2.32<br />

month) in smear +ve cases and the highest was for chest wheezes.<br />

(l3.97month) followed by dyspnea (6.35 month) and cough represented(<br />

3.6 month) and expectation (3.9 month). Similar results were obtained by<br />

Madebo and Lindtjorn (1999) found mean duration for each <strong>symptoms</strong>.<br />

Cough (5.7 month), expectoration (3.8 month) haemoptysis (1.6 month),<br />

chest pain (4.3 month) and dyspnea (2.5 month). Other authors most <strong>of</strong><br />

them worked on the mean duration <strong>of</strong> <strong>symptoms</strong> in toto as Niijima et al.<br />

(1990) in Japan, mean duration was (3.5 month) and Pirkis et al (1996)<br />

from Australia mean duration <strong>of</strong> <strong>symptoms</strong> 72.9± 84.9 day, and also<br />

Wandwalo and Morkve (2000) found mean duration <strong>of</strong> <strong>symptoms</strong> was<br />

185 day.<br />

122


1<br />

r---<br />

tJJircussion<br />

In this study (tab. 22), mean duration <strong>of</strong>non <strong>respiratory</strong> <strong>symptoms</strong><br />

revealed significant difference between smear +ve and smear -ve cases for<br />

fever. The shortest mean duration was fever (1.38 month) in smear +ve<br />

cases. Regarding mean duration (tab. 21, 22) it was noted that haemoptysis,<br />

chest pain and fever had shortest duration and that documented as these<br />

<strong>symptoms</strong> were agonizing so when patient contract any <strong>of</strong> it, he urgently<br />

seeks medical advise.<br />

Analysis <strong>of</strong> duration <strong>of</strong> <strong>symptoms</strong> monthly (tab. 23,24), only (28%)<br />

were diagnosed within one month. And 70% <strong>of</strong> haemoptysis were<br />

diagnosed in Ist month followed by 69.8% <strong>of</strong> chest pain, and no any<br />

haemoptitic case delayed after 6 month, all the other <strong>symptoms</strong> mostly<br />

represented at 1-3 month except chest wheezes that delayed to one year,<br />

and that results was accepted as it confirm the mean duration <strong>of</strong> <strong>symptoms</strong><br />

and also in this study as regard general <strong>symptoms</strong> no any patients<br />

represented more than 6 month. And as regard fever and night sweats it not<br />

beyond 3 months in agreement with this study, Teklu (1993), elucidated<br />

chest pain and haemoptysis were the <strong>symptoms</strong> most agonizing patients to<br />

seek medical advice.<br />

In this study. (tab. 25) it was significantly higher presentation <strong>of</strong><br />

typical CXR lesions in smear +ve than in smear -ve cases for AFB, and<br />

also far advanced lesions was significantly higher in smear +ve (48.1 %)<br />

than smear -ve (5.7%) cases and in contrast mild lesions was higher in<br />

smear -ve than in smear +ve cases in agreement with this results Barnes et<br />

aI. (1988) found high significance <strong>of</strong> typical CXR presentation in smear<br />

+ve than in smear- ve cases and also. Cohen et al. (1996) reported that<br />

typical CXR in smear +ve (79%) was significantly higher than smear -ve<br />

for TB (40%), similar results were recorded by Gamal EL Din (1997) and<br />

123


caseation, the patient usually notice cough and <strong>sputum</strong>, <strong>of</strong>ten associated<br />

with haemoptysis (Rossman and Mayock, 1999).<br />

In this study CT was done for 15 patient, 12 was smear +ve and 3<br />

was smear -ve for AFB. The findings were non significantly different,<br />

although some findings appeared only in smear +ve cases as, nodular and<br />

micronodular, single cavity, multiple small cavities and pleural effusion.<br />

When CT findings were compared with CXR notification some findings<br />

were not apparent in CXR as this in CT e.g. pleural effusion appeared in 3<br />

cases by CT and only one in CXR, multiple small cavities in 2 cases by<br />

C.T. only in one case in CXR, nodular and micro nodular in 4 cases by CT<br />

and only 2 in CXR (tab. 30, 31 ). Many authors reported the role <strong>of</strong> CT in<br />

diagnosis <strong>of</strong> pulmonary T8 as by Lee et al., (1995 and 1996), they<br />

concluded that thin section CT is accurate in specific diagnosis <strong>of</strong><br />

pulmonary tuberculosis, by enabling differentiation <strong>of</strong>active tuberculosis<br />

from inactive lesion, CT also assists in the management <strong>of</strong>tuberculosis.<br />

Table (32) tuberculin skin test positivity in smear +ve cases were<br />

significantly higher than in smear - ve cases. It was 75.3% in smear +ve<br />

and 500/0 in smear -ve cases. Similar results were obtained by Stead (1969)<br />

and Holden et al. (1971) and in our locality similar results reported by<br />

Osman 1993 and Gamal El Din (1997). This results can be explained as<br />

tuberculin test does not discriminate between active TB, past infection with<br />

mycobacteria or BeG vaccinated (Kox, 1995). And also, anergic state was<br />

attributed to compartmentalization <strong>of</strong> sensitize CD4 + T cells to sites <strong>of</strong><br />

active disease may playa role (Rohrbach and william, 1986). Also, ATS<br />

(1978), reported that anergy may not always be due to failure <strong>of</strong> the<br />

immune system to responde but may be the result <strong>of</strong><strong>positive</strong> suppressive<br />

reaction.<br />

125


£Jisctt.fsion<br />

Table (33) showed, mean induration <strong>of</strong>tuberculin test in smear +ve<br />

-»---- 17.5 mm was highly significant than in smear -ve 13.2 mm cases, in this<br />

study +ve tuberculin test in smear -ve cases can be explained as most <strong>of</strong><br />

them were BCG vaccinated, or they get infection and diseased.<br />

When clinical <strong>symptoms</strong> presentation in smear +ve cases were<br />

compared as regard tuberculin test results (tab. 34) no any <strong>symptoms</strong> was<br />

significantly different, and in agreement with this results Garnal EI Din<br />

(1997) found the same result. Their was non significant association<br />

between tuberculin skin test and smoking <strong>among</strong> cases with smear +ve or<br />

smear -ve for APB. But tuberculin test positvity was higher in non smoker<br />

79.7% than in smoker 72.2% in smear +ve cases, also Garnal EI Din<br />

(1997) found lower reactivity in smoker than in non smoker and this can be<br />

explained by Sibille and Reynolds (1990) as tobacco smoke could alter<br />

native and acquired resistance to mycobacterial tubercle bacilli, and<br />

exposure to tobacco smoke causes morphological and functional changes in<br />

the alveolus macrophage with multiple defects in macrophage/monocyte<br />

and CD4 lymphocyte immune responses. The smoking recognized as a<br />

toxic factor capable <strong>of</strong> reducing host defense (Cr<strong>of</strong>ton et al., 1992).<br />

In this study their was non significant difference <strong>of</strong> BCG vaccination<br />

between smear +ve (88.3%) and smear -ve (81.3%) (tab. 36), but<br />

percentage was higher in smear +ve cases than in smear -ve this explained<br />

as BCG has lower degree in protection. Also Altet et al. (1993) concluded<br />

that, the low degree <strong>of</strong> protection afforded by the BeG vaccination<br />

program, and the known harmful effects it causes, make this method <strong>of</strong><br />

little value, and not advisable in tuberculosis programs, also Murhekar et<br />

al. (1995), revealed the similar conclusion that III VIew <strong>of</strong> the low<br />

protective effectiveness <strong>of</strong> BeG vaccination against pulmonary<br />

126


),<br />

....--.<br />

*;- I<br />

i<br />

SUMMAR1(<br />

AND<br />

CONCLUSION


...<br />

J<br />

I<br />

Summary andConclitsion<br />

Summary<br />

This work was conducted to asses specificity and sensitivity <strong>of</strong><br />

<strong>respiratory</strong> <strong>symptoms</strong> in the diagnosis <strong>of</strong> active <strong>sputum</strong> <strong>positive</strong> pulmonary<br />

tuberculosis and this study included 186 patients all with TB like picture.<br />

All patients complaining from <strong>respiratory</strong> <strong>symptoms</strong>. Their ages ranged<br />

from Ia years to 76 years.<br />

All patients were submitted to the following:<br />

- Full medical history.<br />

- Clinical examination.<br />

Radiological investigation, postero-anterior view <strong>of</strong>full- sized ordinary<br />

CXR that prove to be TB like picture, and C.T. chest was done for ] 5<br />

patients.<br />

,,-"·1 - Tuberculin skin test.<br />

Routine laboratory investigations (e. g. CBC, ESR, and post prandial<br />

blood sugar).<br />

- Direct- smear <strong>sputum</strong> examination using Kinyoun's staining methods.<br />

- Sputum negative for AFB were taken as control group.<br />

• The results <strong>of</strong> this study elucidated that:<br />

(1) Prevalence <strong>of</strong> cough on smear +ve for AFB was 97.4% highly<br />

significant than those <strong>of</strong> smear -ve for control cases 62.5%<br />

(P < 0.001). Expectoration percentage in smear +ve for AFB was 87%<br />

129


.Jo.. --<br />

.-1'.<br />

SU1ltlltdryt/1tifConclit.nOn<br />

fever 35.5% haemoptysis 28.8%. No patients complaint from general<br />

<strong>symptoms</strong> <strong>of</strong> more than 6 month duration, but this statement is not<br />

holding good in <strong>respiratory</strong> <strong>symptoms</strong> exceed that period and all<br />

except haemoptysis. Analysis <strong>of</strong> mean duration <strong>of</strong> each symptom<br />

showed that haemoptysis and fever <strong>among</strong> smear <strong>positive</strong> for AFB<br />

were the shortest duration 1.3 ± 0.71 months and 1.38 ± 0.6 months<br />

respectively a result was significantly higher than smear -ve control<br />

group P < 0.002. Mean duration <strong>of</strong> cough and expectoration in smear<br />

<strong>positive</strong> tuberculous cases were 3.6 ± 3.5 months and 3.9 ± 3.7<br />

months respectively and showed non significant deference in<br />

comparison with smear +ve tuberculous cases and smear -ve control<br />

group, P > 0.05. The highest mean duration was chest wheezes<br />

followed by dyspnea 13.97 ± 15.9 months, 6.35 ± 10.1 months<br />

respectively, P> 0.05 ..<br />

(5) Symptoms which were significantly higher in smear +ve than in smear<br />

-ve for AFB (Cough, expectoration and weight loss) when combined<br />

represents 44.20/0 in smear +ve and 23% in smear -ve and was<br />

significantly different (P < 0.019) and when added to typical CXR<br />

presentation the significance was increased P < 0.014. And noted in this<br />

study some combined <strong>symptoms</strong> (Cough either dry or productive and<br />

haemoptysis and dyspnea and fever and loss <strong>of</strong> weight) with typical<br />

CXR and +ve tuberculin skin test only presented in smear +ve for<br />

AFB. And not present in smear -ve for AFB.<br />

(6) Some risk factors (TB contact and D.M and smoking). Prevalence <strong>of</strong><br />

smoking in smear +ve 58.4% and smear -ve 31.3% was significantly<br />

different between smear +ve and smear -ve for AFB (P < 0.01) and<br />

131


41.7%, 33%, calcified nodules 16.75%, 66% nodular and micro<br />

nodular 33% ,0% and single cavity 33%, 0% , multiple small cavities<br />

16.75% , 0%, bronchial dilatation 16.75%,33% and pleural effusion<br />

25%, 0% and there were non significantly difference in CT finding in<br />

comparison to CXR findings <strong>of</strong> the same patients only bronchial<br />

dilatation appeared in C.T (13.3%) CXR 0% pleural effusion in CT<br />

20% and in CXR (6.7%) and multiple small cavities in CT 13.3% and<br />

in CXR 6.7%.<br />

(9) Specificity and sensitivity <strong>of</strong> <strong>symptoms</strong> were for cough 37.5% , 97.4%<br />

expectoration 50%, 87%, chest pain 71%, 34.4%, haemoptysis 59.4%,<br />

51.9%, dyspnea 53. I%, 50%, fever 46. I%, 60.4% night sweating<br />

59.4%, 40.3%, weight loss 65.6%,51.9% and anorexia 75%,37.3%<br />

and CXR typical 78.1 % , 58.4% and +ve tuberculin skin test 50%,<br />

75.3%. When these separate <strong>symptoms</strong> were combined with each<br />

other specificity was improved as combined (Cough + expectoration<br />

and weight loss) specificity 78.1 % and sensitivity 44.2% and when<br />

these combined <strong>symptoms</strong> added to typical CXR presentation<br />

specificity 90.6% and sensitivity 30.5% and when cough dry or<br />

productive, haemoptysis, dyspnea, weight loss, fever and typical CXR<br />

presentation and +ve tuberculin test specificity = 100% sensitivity<br />

7.8% and <strong>positive</strong> predictive value 1000/0 and negative predictive<br />

value 18.4%.<br />

(lO) Symptoms presentation according to age group < 20y, 20- 40y and<br />

>40y in smear +ve cases expectoration were significantly higher in<br />

age f,JTOUp 20-40y 91.1 % and > 40y 94.1 % and lower in


Sum1lldrytlndConclitstOn<br />

group> 40y 64.7% and lower in young group < 20y (33.3%) and<br />

chest wheezes was significantly higher in older group> 40y 54.9%<br />

and 0% in younger group < 20y and night sweats and anorexia were<br />

significantly higher in older group > 40y. Represented 56.8% and<br />

52.9% respectively and the rest <strong>of</strong> <strong>symptoms</strong> cough. Chest pain fever<br />

and weight loss were distributed nearly with near percentage in all<br />

groups.<br />

lJ4


.....<br />

SUlIlfltdry11MConclU.non<br />

Conclusions<br />

1- Haemoptysis, chest pain and fever were the <strong>symptoms</strong> urging the patient<br />

to seek medical advise rapidly in comparison to other <strong>symptoms</strong>.<br />

2- Haemoptysis in middle age group, dyspnea, anorexia and night sweating<br />

in elderly age group and expectoration in both middle and elderly age<br />

group were statistically significant <strong>symptoms</strong> <strong>among</strong> <strong>sputum</strong> +ve cases<br />

for AFB in relation to age groups.<br />

3- Specificity <strong>of</strong>common <strong>respiratory</strong> <strong>symptoms</strong> are as follow:<br />

Chest pain 71%, Haemptysis 59.4%, dyspnea 53.1%, expectoration<br />

50% and cough 37.5%<br />

4- Specificity <strong>of</strong> common general <strong>symptoms</strong> are as follow:<br />

Anorexia 75%, weight loss 65.6%, night sweat 59.4% and fever<br />

46.6%.<br />

..,.--- 5- Sensitivity <strong>of</strong>common <strong>respiratory</strong> <strong>symptoms</strong> proved to be :<br />

Cough 97.4%, expectoration 87%, haemptysis 51.9%, dyspnea 50%<br />

and chest pain 34.4%.<br />

6- Sensitivity <strong>of</strong> common general <strong>symptoms</strong> are:-<br />

Fever 60.4%, weight loss 51.9%, night sweat 40.3% and anorexia<br />

27.3%<br />

7- In an Egyptian community Cough dry or productive, haemoptysis,<br />

dyspnea, weight loss and fever <strong>among</strong> smokers were highly suggestive<br />

<strong>of</strong> pulmonary tuberculosis. This statement holds more good when TB<br />

like picture and +ve tuberculin test are present.<br />

115


I ... _-<br />

." I<br />

RECOMMENDATIONS


REFERENCES


1({ftrences<br />

AlJerberger F., Fille M., Streif W. et al. (1994): Microbiological<br />

diagnosis <strong>of</strong> tuberculosis. Wien. Med. Wochenschr, 144<br />

(8-9): 156-62.<br />

Alouch J.A., Edwards E.A., Stott H., Fox W. and Sutherland LA.<br />

(1982): Fourth study <strong>of</strong> case - finding methods for<br />

pulmonary tuberculosis in Kenya. Trans. Soc. Trop. Med.<br />

Hyg., 76: 679- 691.<br />

Altet N., Alcaide J., Canela J. et al. (1993): Retrospective evaluation <strong>of</strong><br />

4--- the efficacy <strong>of</strong> the BeG vaccination campaign <strong>of</strong> newborns<br />

in Barcelona, Spain. Tuberc. Lung Dis., 74: 100-5.<br />

Andersen P (1994) : The T cell response to secreted antigens <strong>of</strong><br />

mycobacterium tuberculosis. Immunobiology, 191: 537­<br />

547.<br />

Andersen P, Andersen AB, Sorensen AL and Nagai S (1995) : Recall <strong>of</strong><br />

long-lived immunity to mycobacterium tuberculosis<br />

infection in mice. 1. Immunol., 154: 3359- 3372.<br />

Anderson P., Askgaard D., Gottschau A. et al. (1992): Identification <strong>of</strong><br />

immunodominant antigens during infection with M. TB.<br />

Scand. 1. Immunol., 36 : 823-831.<br />

Ando M., Dannenberg A.M., Sugimoto M. and Tepper B.S. (1977) :<br />

Histo-chemical studies relating the activation <strong>of</strong><br />

macrophages to the intracellular destruction <strong>of</strong> tubercle<br />

bacilli. Am. 1. Pathol., 86: 623- 634.<br />

138


Baily G.V.J., Savic D., Gothi G.D, et al. (1967): Potential yield <strong>of</strong><br />

pulmonary tuberculosis cases by direct microscopy <strong>of</strong><br />

<strong>sputum</strong> in a district <strong>of</strong> South India. Bull world Health<br />

Organ, 37: 875-892.<br />

Banerji D. and Anderson S.A. (1963): Sociological study <strong>of</strong> awareness <strong>of</strong><br />

<strong>symptoms</strong> <strong>among</strong> persons with pulmonary tuberculosis.<br />

29: 3665- 683.<br />

Barany F. (1991): Genetic disease detection and DAN amplification using<br />

cloned thermostable ligase. Proc. Nat!. Acad. Sci. USA,<br />

88: 189.<br />

Barnes P. F., Bloch A. B., Davidson P.T. and Snider D.E. (1991):<br />

Tuberculosis in patients with human immunodeficiency<br />

virus infection. New England J. Med., 324: 1644- 50.<br />

Barnes P.F. (1997): Rapid diagnostic tests for tuberculosis, progress but no<br />

gold standerd. Am. J. Respir. Crit. Care Med., 156- ]022.<br />

Barnes P.F., Fong S.J., Brennan P.J. et al. (1990): Local production <strong>of</strong><br />

tumor necrosis factor and IFN- gamma in tuberculous<br />

pleuritis. J. Immunol., 145:149- 154.<br />

Barnes P.F., Verdegem T.n., Vachon L. A. et al. (1988): Chest<br />

roentgenogram in pulmonary tuberculosis: new data on an<br />

old test. Chest, 94: 316-20.<br />

.j-I Bass J.B., Farer L.S. and Hopewn P.C. (1990): Diagnostic standerds and<br />

L_<br />

classification <strong>of</strong>tuberculosis. Am. Rev. Respir. Dis., 142: 725.<br />

140


Bates S., Holm G. and Gakek J.S. (1982): Sputum examination in<br />

:..-- pulmonary tuberculosis. Tubercle, 18: 9.<br />

Baynes R.D., Flax H., Bothwell T.H. et al. (1986): Red blood cell<br />

distribution width in the anemia secondary to tuberculosis.<br />

Am. 1. Chn. Pathol., 85: 266-229.<br />

Belosevic M., Davis C. E., Meltzer M. S., Nacy C.A. et al. (1988):<br />

Regulation <strong>of</strong> activated macrophage antimicrobial<br />

activities: Identification <strong>of</strong> lymphokines that cooperate<br />

with IFN-gamma for induction <strong>of</strong>resistance to infection. J.<br />

Immunol., 141: 890- 896.<br />

Berke G. (1995): Unlocking the secrets <strong>of</strong>CTL and NK cells. Immunol.<br />

Today, 16: 343- 346.<br />

Beutler B. (1995): TNF, Immunity and inflammatory disease: Lessons <strong>of</strong><br />

the past decade. J. Invest. Med., 43: 227- 235.<br />

,); \ Bloch A. B., Reider H. L., Kelly G. D. et al, (1989): Epidemiology <strong>of</strong><br />

tuberculosis in the united stated. Clin. Chest. Med., 10: 297.<br />

Bloch A.B. (1998): Mycobacterial infections: Screening for tuberculosis<br />

and tuberculosis infection in high-risk populations. In<br />

Fishman's pulmonary disease and disorders. Fishman AP.<br />

et aI. (eds) 4th editions, MC. Graw. Hill Health Pr<strong>of</strong>essions<br />

division New- York, PP : 2474.<br />

+-- Bloom .J. D. (1969): Glucose intolerance in pulmonary tuberculosis. Am.<br />

Rev. Respir. Dis., 100: 38.<br />

141


Boddinghaus B., Rogall T., Flohr T. et al. (1990): Detection and<br />

...- identification <strong>of</strong> mycobacteria by amplification <strong>of</strong>rRNA.<br />

I<br />

¥I<br />

I<br />

.s- , I<br />

1. Clin. Microbiol., 28(8): 1751- 9.<br />

Body B. A., Warren N. G., Spicer A. et al. (1990): use <strong>of</strong>Gen- probe and<br />

BACTEC for rapid isolation and identification <strong>of</strong><br />

mycobacteria. Am. J Chn. Pathol., 93: 415.<br />

Borish L. and Rosewasser L. (1997): Th1/Th2 lymphocytes: Doubt some<br />

more. 1. Allergy Chn. Immuno!., 199:161 -164.<br />

BradenC. R. and an investigative team (1995): Infectiousness <strong>of</strong> an<br />

university student with laryngeal and cavitary tuberculosis.<br />

Clin. Infect Dis., 21: 1565- 1570.<br />

Braden C.R. (1995): and an investigative team: Infectiousness <strong>of</strong> an<br />

university student with laryngeal and cavitary tuberculosis.<br />

Clin. Infect Dis., 21: 1565-1570.<br />

Brennan P..J. (1989): Structure <strong>of</strong> mycobacteria: recent developments in<br />

defining cell wall carbohydrates and proteins. Rev. Infect.<br />

Dis., 11 (suppl): 420.<br />

Brisson - Noel A., Aznar C., Chureau C. et al. (1991): Diagnosis <strong>of</strong><br />

tuberculosis by DNA amplification in clinical practice<br />

evaluation. Lancet, 338(8763): 364- 6.<br />

Callard R.E. and Gearing A.J.H. (1994): The cytokine facts book. San<br />

Diego, Academic Press.<br />

142


.../<br />

,.c I<br />

I<br />

L<br />

Choyke P.L., Sostman H.D., Curtis A.M. et al. (1983) : Adult onset <strong>of</strong><br />

pulmonary tuberculosis. Radiology, 148: 537.<br />

Cohen D..1. and Henkart P.A. (1994) : Cytolytic T-cel1 development and<br />

function. In Snow EC, ed: Handbook <strong>of</strong> Band T<br />

lymphocytes. New York, Academic Press.<br />

Cohen R., Muzaffar S., Capellan J. et al. (1996): The validity <strong>of</strong> classic<br />

<strong>symptoms</strong> and chest radiographic configuration III<br />

predicting pulmonary tuberculosis. Chest, 109: 420- 3.<br />

Cooper A.M. and Flynn J.A. (1995): The protective immune response to<br />

mycobacterium tuberculosis. Curro Opin. Immunol., 7:<br />

512- 516.<br />

Cox D.A. and Maurer T. (1997): Transforming growth factor-B. Clin.<br />

Immunol. lmmunopathol., 83: 25- 30.<br />

Crawford J.T. (1995): New developments for the diagnosis <strong>of</strong>tuberculosis:<br />

The impact <strong>of</strong> molecular biology. In: Rossman l\1D,<br />

MacGregor RR (eds). Tuberculosis: clinical management<br />

and new challenges, McGraw- Hill Inc., 255-73.<br />

Cr<strong>of</strong>ton .1., Horne N. and Miller F. (1992): Clinical tuberculosis. The<br />

MacMillan Press Ltd. Hong Kong.<br />

Cr<strong>of</strong>ton .J.W. (1954): Some problems in primary tuberculosis. Br. Med.<br />

Bull., 10: 125.<br />

144


Jfr#rences<br />

Engvall E. and Perlman P. (1972): Enzyme- Linked immunosorbent<br />

assay ELISA III. Quantitation <strong>of</strong> specific antibodies by<br />

enzyme labelled immunoglobin in antigen coated tubes. 1.<br />

Immuno!.,109:129<br />

Erlich H.A., Gelf D.H. and Sninsky J.J. (1991): Recent advances in peR.<br />

Science, 252: 1643.<br />

Farer L. S. (1990): All about T8. What the practicing physician must<br />

know and can do about tuberculosis. Clinical Notes on<br />

Respiratory Diseases, 16: 3.<br />

Feldmann M., Brennan F. M. and Maini R.N. (1996): Role <strong>of</strong>cytokines in<br />

rheumatoid arthritis. Annu. Rev. Immunol., 14: 397- 440.<br />

Festenstein F. (1984): Tuberculosis in hospital doctors. Br. Med. 1., 289,<br />

1327.<br />

• / I Fine P.E.M. (1989): The BeG story: lessons from the past and<br />

implications for the future. Rev. Infect. Dis., 11 (suppl) :<br />

5353-9.<br />

Finegold M.S. and Baron J.E. (1986) : Mycobacteria In: Baily Scott's<br />

Diagnostic microbiology, i h ed., Mosby, 594.<br />

Fodor T. (1995): Detection <strong>of</strong>mycobacteria in <strong>sputum</strong> smears prepared by<br />

cytocentrifugation. Tub. Lung Dis., 76:273-4.<br />

Fox W. (1980): Tuberculosis in white and negro chidden. Am. Rev.<br />

Respir. Dis., 101: 419.<br />

148


\ Frei R. (1993): Current methods in rapid diagnosis <strong>of</strong> tuberculosis.<br />

-"" Schweiz Med. Wochenschr, 123(5): 147-52.<br />

I<br />

Frette C., Wei S.M., Neukirch F. et al. (1992): Relation <strong>of</strong> serum elastin<br />

peptide to age, FEYl and smoking habit. Thorax, 47: 937.<br />

Funahashia A., Lohaus G.H., Politis J. and Hranickal J. (1983): Role <strong>of</strong><br />

fibreoptic bronchoscopy in the diagnosis <strong>of</strong> mycobacterial<br />

diseases. Thorax, 38: 260.<br />

Furie M.B. and Randolph G.J. (1995): Chemokines and tissue injury.<br />

Am. 1. Pathol., 146: 1287- 1301.<br />

Gamal EI-Din S.M. (1997): Polymerase chain reaction and diagnosis <strong>of</strong><br />

tuberculosis: Thesis for MD degree in Chest Diseases,<br />

Zagazig University.<br />

Geiseler P.J, Nelson K.E. and Crispen R.C. (1987): Tuberculosis in<br />

physicians. Compliance with preventive measures. Am.<br />

Rev. Respir. Dis., 135, 31.<br />

Gerbeaux J., Baculard A. and Couvreur J. (1965): Primary tuberculosis<br />

III childhood. Indication and contraindications for<br />

corticosteroid therapy: observation on 677 treated cases.<br />

Am. 1. Dis. Child., 110 : 507.<br />

Gie R.P., Beyers N., Schaf H.S. and Donald P. R. (1993): Missed<br />

opportunities in the diagnosis <strong>of</strong>pulmonary tuberculosis in<br />

children. South Africa Med. 1., 83 (4) : 263.<br />

149


\<br />

--- \<br />

;/1


\ _.--:<br />

l-<br />

\<br />

diagnostic mocrobiolgy. 5 th<br />

Philadeliphia, New York Ch. 17, PP: 904-.<br />

edition, Lippincott,<br />

Kox L. F. F., van Leeuwen .I., Knijper S. et al. (1995): peR assay based<br />

on DNA coding for 16S rRNA for detection and<br />

identification <strong>of</strong> mycobacteria clinical samples. 1. Clin.<br />

Microbiol., 33 (12): 3225- 33.<br />

Kramer F., ModiJevsky T., Waliany A. R. et al. (1990): Delayed<br />

diagnosis <strong>of</strong> tuberculosis in patients with HIV infection.<br />

Am. Med., 89: 451.<br />

Kubica G., Parks P. E. and Berg K. (1989): Pathogenesis <strong>of</strong> pulmonary<br />

tuberculosis. Chest, 88 (3): 139- 42.<br />

Kunkel S. L., Strieter R. M., Lindley V.D. and Westwick J. (1995):<br />

Chemokines: New ligands, receptors and activities.<br />

Immunol. Today, 16: 559- 561.<br />

+- Kuyp F.V. (1998) : The microbiology <strong>of</strong>the mycobacteria. In : Fishman's<br />

pulmonary diseases and disorders. Fishman A.P. et al.<br />

(eds) 4 th edition. McGraw Hill Health Pr<strong>of</strong>essions division,<br />

New York, PP. : 2442.<br />

Lasley .I., Burgess M. B., Frans J. et al. (1996): Combined use <strong>of</strong><br />

pleural adenosine deaminase with lymphocyte/neutrophil<br />

ratio: increased specificity for the diagnosis <strong>of</strong>tuberculous<br />

pleuritis. Chest, 109(2): 414-419.<br />

155


J(r#rencef<br />

Lordi G. M. and Reichman L. B. (1999): Tuberculin skin testing. In<br />

tuberculosis and non tuberculous mycobacterial infections,<br />

Schoolssberg D., M. D. (eds) 4 th edition, W.B. Saunders<br />

division <strong>of</strong> Harcourt Brace and company London. Ch.5,<br />

PP.: 65.<br />

Lovie E., Rice L.B. and Holzman R. S. (1986): Tuberculosis in non-<br />

Haitian patients with acquired immunodeficiency<br />

syndrome. Chest, 90: 542.<br />

Luger T.A. and Schwarz T. (1995) : The role <strong>of</strong> cytokines and<br />

neuroendocrin hormones in cutaneous immunity and<br />

inflammation. AlIerg., 50: 292- 302, 1995.<br />

Lurie M.B. (1964): Resistance to tuberculosis: Experimental studies in<br />

Native and Acquired Defense Mechanisms. Cambridge, M.<br />

A., Harvard University Press.<br />

Maartens G., Willcox P. A. and Benatar S. R. (1990): Millary<br />

tuberculosis: Rapid diagnosis, hematologic abnormalities,<br />

and out come in 109 treated adults. Am. 1. Med., 89- 291.<br />

Mackaness G. B. (1968): The immunology <strong>of</strong> antituberculous immunity<br />

[Editorial]. Am. Rev. Respir. Dis., 97: 337- 344.<br />

Madebo T and lindtjcrn B. (1999): Delay in treatment <strong>of</strong>pulmonary<br />

tuberculosis: An analysis <strong>of</strong> symptom duration <strong>among</strong><br />

Ethiopian patients. Med. Gen Med. June 18, C Med.<br />

Scape. Inc.<br />

157


Mall<strong>of</strong>re c., Bombi J. A., Palacin A. and Cardesa A. (1988):<br />

.}..--- Tuberculosis in Spain. A study <strong>of</strong> necrosis (English<br />

Abstr.). Med. Clin. (Bav.), 90 : 735-8.<br />

Mangan D.F. and Wahl S.M. (1991): Differential regulation <strong>of</strong> human<br />

monocyte programmed cell death (apoptosis) by chemo­<br />

tactic factors and pro- inflammatory cytokines. J.<br />

Immunol., 147: 3408- 3412.<br />

Martin D. J. and Gelfand E.W. (1981): Biochemistry <strong>of</strong> diseases <strong>of</strong><br />

immuno-development. Ann. Rev. Biochem., 50: 845-77.<br />

Martins LM and Earnshaw we (1997) : Apoposis: Alive and kicking in<br />

1997. Trends. Cell BioI., 7:111- 114.<br />

Marvisi M., Marani G., Brianti M. and Della-Porta R. (1996) :<br />

Pulmonary complications III diabetes mellitus. Recent.<br />

Prog. Med., 87 (12) : 623-627.<br />

''-ft- Massaro D., Katz S. and Sachs M. (1964): Choroidal TB: a clue to<br />

hematogenous tuberculosis. Am. Intern. Med., 60: 231.<br />

Mathur P., Sacks L., Auten G., Sail R., Levy C. and Gordin F. (1994) :<br />

Delayed diagnosis <strong>of</strong> pulmonary tuberculosis in city<br />

hospitals. Arch Int. Med., 154 : 306-310.<br />

Matthews R., Scoging A. and Rees A.n.M. (1985) : Mycobacterial<br />

antigen-specific human T-cell clones secreting<br />

.. macrophage activating factors. Immunology, 54 : 17.<br />

158


.""-.<br />

'-«:'""<br />

McNeil M. R., Besra G. and Send Brennan P. J. (1994): Chemistry <strong>of</strong><br />

the mycobacterial cel1 wall. In tuberculosis Rom. W. N. et<br />

al (eds), Little, Brown and Company, New York, PP., 171.<br />

McNicol, M. W., Campbell I. A. and .Ienkins P. A. (1995): tuberculosis<br />

clinical features and management. In Respiratory<br />

Medicine, Brewis. R. A. L. et al. (eds) 2 nd editions W.B.<br />

Saunders Company L70, London, 30 (20) : 805.<br />

Migliori G. B., Borghesi A. and Rossanigo P. L. (1990) : Gastric<br />

washing and diagnosis <strong>of</strong>pulmonary tuberculosis in under<br />

5 year children in developing countries. Am. Rev. Respir.<br />

Dis., 141 (4): 788.<br />

Miller F.J.W., Seal RME and Taylor MD. (1963): Tuberculosis III<br />

children. l& A., Churchill, London.<br />

Miller L.G., Goldstein G., Murrphy M. and Ginns L.G. (1982) :<br />

Reversible alterations in immuno- regulatory T cel1s in<br />

smoking. Chest, 5: 525.<br />

Miller W. T. and Miller W. T. (1993): Tuberculosis III normal host.<br />

Semin. Roentgenol., 28: 109.<br />

Minnikin D. E., Bolton R. C., Hartmann S. et at. (1993): An integrated<br />

procedure for the direct detection <strong>of</strong> characteristic lipids in<br />

tuberculosis patients. Ann. Soc. Belg. Med. Trop, 73<br />

(supp!1): 13-24.<br />

Minninkin D. E. and Goodfellow M. (1980) : Lipid composition in the<br />

classification and identification <strong>of</strong> acid - fast bacteria. In :<br />

159


Nassau E., Pearson E. and Nagai S. (1996) : Detection <strong>of</strong>antibodies to<br />

M. tuberculosis by solid phase radioimmunoassay. J.<br />

Immunology, 6 : 261.<br />

Nathan C. (1991): Mechanisms and modulations <strong>of</strong> macrophage<br />

activation. Behring. lnst. Mitt., 88: 200- 207.<br />

Nathan CF (1987) : Secretory products <strong>of</strong>macrophages. 1. Clin. Invest.,<br />

79: 319- 326.<br />

National TB Association <strong>of</strong> the USA (1961) : Diagnostic standards and<br />

classification <strong>of</strong> tuberculosis. In: Seaton A, Seaton D,<br />

Leitch AG (eds). Cr<strong>of</strong>ton and Douglas's <strong>respiratory</strong><br />

diseases. New York, National TB Association, 4 th ed.,<br />

1989. Blackwell Scientific Publications, 409- 410.<br />

National Tuberculosis Control Programme. (1998): Epidemiology <strong>of</strong><br />

tuberculosis, Annual risk <strong>of</strong> infection. In: Tuberculosis<br />

control guide: Cairo, November, 2:9.<br />

Negm R.I.M. (1984): Pattern <strong>of</strong> tuberculosis <strong>among</strong> BCG vaccinated<br />

patients versus non-vaccinated. Thesis for master's degree<br />

in Chest Dis., Zagazig Univ.<br />

New Scientist (1993): Early tuberculosis test. Quoted in: Medical Digest,<br />

19(12): 10.<br />

Niijima Y., Yamagishi F., Suzuki K., Yasuda T., Shirai T., Satoh N. et<br />

al. (1990): Patient's delay and doctor's delay in the<br />

162


pnmary treatment cases <strong>of</strong> pulmonary tuberculosis.<br />

Kekkaku, 65: 609-13.<br />

Noel A.B., Cicquel B., Lecossur D. et at (1989) : Rapid diagnosis <strong>of</strong>TB<br />

by amplification <strong>of</strong> mycobacterial DNA in clinical<br />

samples. Lancet, 2 : 1069-1071.<br />

Noordhoek G.T., Kolk AH.J., Bjunee G., Catty D., Dale J.W., Fine P.E.<br />

et at (1994): Sensitivity and specificity <strong>of</strong> P.C.R., for<br />

detection <strong>of</strong> mycobacterium tuberculosis :a blind<br />

comparison study <strong>among</strong> seven laboratories. .J. Clin.<br />

Microbiol., 32: 277- 84.<br />

Nsanzumuhire H., Lukwago E. W. and Edwards E. A. A. (1977): <strong>Study</strong><br />

<strong>of</strong> the use <strong>of</strong> community leaders in case- finding for<br />

pulmonary tuberculosis in the Machakos district <strong>of</strong> Kenya.<br />

Tubercle., 58: 117- 128.<br />

Onorato I. M. and Ridzon R. (1998): Mycobacterial infections: The<br />

epidemiology, transmission and prevention <strong>of</strong> tuberculosis in<br />

the United Stated. In Fishman's pulmonary disease and<br />

disorders, Fishman A .P. et al. (eds) 4 th edition. MC Graw­<br />

Hill Health pr<strong>of</strong>essions divisions. New- York, PP 2431- 40.<br />

Orme I.M., Anderson P. and Boom W.H. (1993) : T-cell responses toM.<br />

TB. J. Infect. Dis., 167 : 1481-1497.<br />

'I" Osborne B.A. (1996): Apoptosis and the maintenance <strong>of</strong> homeostasis in<br />

the immune system. Curr Opin Immunol, 8: 245- 254.<br />

163


Patel K.R. (1985): Pulmonary tuberculosis in residents <strong>of</strong>lodging houses,<br />

night shelters and common hostels in Glasgow: a 5- Year<br />

prospective study. Br. 1. Dis., Chest 79, 60.<br />

Peat J.K., Woolcock A. J. and Cullenk (1990): Decline in lung function<br />

and development <strong>of</strong> chronic airflow limitation: a<br />

longitudinal study <strong>of</strong> nonsmokers and smokers in<br />

Busselton western Australia. Thorax, 45: 32.<br />

Pettersson T., KJockars M. and Weber T. (1984): Pleural fluid adenosine<br />

• . deaminase rheumatoid and systemic lupus erythromatosis.<br />

Chest, 86 (2): 273.<br />

-+<br />

Pirkis J. E., Speed B. R., Yung A. P., Dunt D. R., MacIntyre C.R. and<br />

plant A.J. (1996): Time to initiation <strong>of</strong>anti- tuberculosis<br />

treatment, Tub. and Lung Dis., 77:401-406.<br />

Pober JS and Cotran RS (1990) : The role <strong>of</strong> endothelial cells in<br />

information, Transplantation, 50 : 537-544.<br />

Pomputius W.F., Rost J., Dennehy P.H., et al. (1997): Standardization<br />

<strong>of</strong> gastric aspirate technique improves yield in the<br />

diagnosis <strong>of</strong> tuberculosis in children. Pediater Infect. Dis.<br />

1., 16 (2): 222-226.<br />

Poppius H. and Thomander K (1957) : Segmentary distribution <strong>of</strong><br />

cavities: A radiologic study <strong>of</strong> 500 consecutive cases <strong>of</strong><br />

cavernous pulmonary tuberculosis. Ann. Med. Intern.<br />

Fenn., 46: 113.<br />

165


Retzinger G.S., Meredith S.C., Takayama K. et al. (1981): The role <strong>of</strong><br />

:,.._. surface in the biological activities <strong>of</strong> trehalose 6.6­<br />

--f i<br />

1 I<br />

dimycolate. 1. BioI. Chern., 256 : 8208.<br />

Richards G. A., Theron A. J., Van de Merwe C. A. and Anderson R.<br />

(1989): Spirometric abnormalities in young smokers<br />

correlate with increased chemiimmuinescence responses <strong>of</strong><br />

activated blood phagocytes. Am. Rev. Respir. Dis" 139:<br />

181- 7.<br />

Richeldi L., Barnini S. and Saltini C. (1995) : Molecular diagnosis <strong>of</strong><br />

tuberculosis. Eur. Respir. 1., 8 (supp 20) : 689s-700s.<br />

Rietbroek R. C., Dahlmans R. P. M., Smedis R. et al. (1991):<br />

Tuberculosis cutis miliaris dissminata as a manifestation <strong>of</strong><br />

miliary tuberculosis: Literature review and report <strong>of</strong>a case<br />

<strong>of</strong> recurrent skin lesions, Rev. Infect. Dis" 13: 265.<br />

Riley R.L. (1974): Air borne infection. Am. T. Med., 57: 466- 475.<br />

Roberts G. D., Koneman E. W. and Kim Y. K. (1991): Mycobacterium.<br />

In: Balows A., Hausler W. 1., Herrmann K. L. et al, (eds).<br />

Manual <strong>of</strong> clinical Microbiology. 5 th ed. Washington, DC<br />

American Society for Microbiology, 304.<br />

Roberts J.e. and Blair L.G. (1950): Bronchiectasis III pnmary<br />

tuberculous lesions associated with segmental collapse<br />

Lancet I, 386,<br />

Rohrbach F. S., William D. E. (1986): T- lymphocytes and pleural<br />

tuberculosis. Chest, 89: 473.<br />

167


Romagnani S. (1994): Lymphokine production by human T cells m<br />

disease states. Annu. Rev. Immunol., 12: 227- 257.<br />

Rook G.A.W (1990): Mycobacteria, cytokines and antibiotics. Pathol.<br />

BioI., 38: 276- 280.<br />

Rossman M. D. and Mayock R. L. (1999): Clinical tuberculosis,<br />

pulmonary tuberculosis. In: Tuberculosis and non<br />

tuberculous mycobaterial infections, Schloossberg D.,<br />

(eds) 4 th edition, W.B. Saunders Company, Division <strong>of</strong><br />

• Harcourt Brace and Company, London, Ch, 13: P, 143-.<br />

..-- I<br />

Rossman M. D. and Oner- Eyuboglu A. F. (1998): Mycobactrial<br />

infection: Clinical presentation and treatment <strong>of</strong><br />

tuberculosis. In: Fishman's pulmonary disease and<br />

disorder, Fishman AP., et a1. (eds) 4 th edition. MC Graw­<br />

Hill Health Pr<strong>of</strong>essions Division New - York, PP : 2483-.<br />

Rossman MD. and Mayock RL.(l995): Pulmonary tuberculosis. In:<br />

Rossman MD, MacGregor RR (eds). Tuberculosis: clinical<br />

management and new challenges, 145- 55, McGraw- Hill<br />

Inc.<br />

Rothstein J. L., Esiri M. M. and Rees R. (1990): A comparison <strong>of</strong> the<br />

growth <strong>of</strong> selected mycobacteria. Tubercle, 28: 117.<br />

Rubin R. H. (1980): Infection in the immuno- suppressed host, Scient.<br />

Am. Med., 7:2.<br />

16H


;-J Saceanu C.A., Pfeifer N.C. and McLean T. (1993): Evaluation <strong>of</strong><strong>sputum</strong><br />

--J/I-'\<br />

I smear concentrated by cytocentrifugation for detection <strong>of</strong><br />

I<br />

I<br />

acid. fast bacilli. J. Clin. Microbiol., 31 :2371-2374.<br />

Sahn S. A. and Neff T. A. (1974): Miliary tuberculosis, Am. J. Med., 56:<br />

495.<br />

Saleh M. A. (1988): Newly discovered cases <strong>of</strong>pulmonary tuberculosis in<br />

Cairo during the year 1987. Thesis for master's degree in<br />

Chest, Dis. Ain Shams University.<br />

Salem E. S., Abou El-Enin M. and EI-Hayeg O.M.M.R. (1976): Survey<br />

<strong>among</strong> Zagazig University students. Egypt J. Chest Dis.,<br />

Tubercul., 19(1):83- 9.<br />

Salem E. S., Seoudy M. and Abdel-Latif E. A. A. (1972): Tuberculosis<br />

prevalence survey <strong>among</strong> medical students and hospital<br />

nurses. Egypt J. Chest Dis. Tubercul., 15(2): 131- 40.<br />

Salem E.S., Sharaf EI·Din M., Hassan F. and Daoud W. (1989):<br />

Adenosine deaminase activity in pleural effusion. Egypt J.<br />

Chest Dis. Tubercul., 36 (1): 47-64.<br />

Samai G. C. (1979): Efficacy <strong>of</strong> BeG test in diagnosis <strong>of</strong> childhood<br />

tuberculosis. Indian J. Pediatr., 46: 279-81.<br />

Savic B., Sjobring V., Alugupalli S., et al. (1992): Evaluation <strong>of</strong>PCR,<br />

tuberculostearic acid analysis, and direct microscopy for<br />

the detection <strong>of</strong> M.TB in <strong>sputum</strong>. J. Infect. Dis., 166(5):<br />

1177-80.<br />

169


Schultze J, Nadler LM. and Gribben J.G. (1996) : B7-mediated<br />

costimulation and the immune response. Blood Rev., 10:<br />

111-127.<br />

Scott P, and Trinchieri G. (1995): The role <strong>of</strong> natural Killer cells in host­<br />

parasite interactions. Curro Opin. Immuno., I 7: 34- 40.<br />

Seal R.M.E. (1971): The pathology <strong>of</strong> tuberculosis. Sr. J. Hosp. Med.,<br />

5 : 783.<br />

Seaton A, Seaton D. and Leitch AG. (1989): Cr<strong>of</strong>ton and Douglas's<br />

<strong>respiratory</strong> diseases, 4 th ed. New York: National TB<br />

Association, Blackwell Scientific publication, (Chapter 13,<br />

14) 367-422.<br />

Shim S. A., Spech J., Glenn J. T. and Munday B. (1989): Serological<br />

means in the daignosis <strong>of</strong> pulmonary tuberculosis. Int Arch<br />

Allerg. Appl. ImmunoI., 114: 28- 34.<br />

,...x, Shima K., Dannenberg A.M., Ando M. et al. (1972): Macrophage<br />

accumulation, division. Maturation, and digestive and<br />

microbicidal capacities in tuberculous lesions: 1. Studies<br />

involving their incorporation <strong>of</strong> tritiated thymidine and<br />

their content <strong>of</strong> lysosomal enzymes and bacilli. Am. J.<br />

PathoI.,67: 159-180.<br />

Sibilli Y. and Reynolds H.Y. (1990): State <strong>of</strong>the art. macrophages and<br />

polymorphonuclear neutrophils in lung defense and injury.<br />

Am. Rev. Respir. Dis., 141: 471-501.<br />

170


Smith F.E. and Palmer D.L. (1976): Alcoholism, infection and altered<br />

host defences: a review <strong>of</strong> clinical and experimental<br />

observations. 1. Chron. Dis., 29, 35.<br />

Smyth M.J. and Trapani J. A. (1995): Granzymes : Exogenous protein ­<br />

ases that induce target cell apoptosis. Immunol. Today, 16:<br />

202- 206.<br />

Snider D. E. (1978): The relationship between tuberculosis and silicosis.<br />

Am. Rev. Respir. Dis., 118, 455.<br />

Snider D.E. (1982): The tuberculin skin test. Am. Rev. Respir. Dis., 125<br />

(2) : l08.<br />

Soon C.P. (1979): Time factor in the detection <strong>of</strong> bacillary cases <strong>of</strong><br />

tuberculosis. Bull. Int. Un. Against Tuber., 54(2): 194.<br />

Stead W.W. (1969): The new face <strong>of</strong>tuberculosis. Hosp Prac, 4:62.<br />

Stead W.W., Senner J.W., Reddick W.T. and L<strong>of</strong>gren J.P. (1990): Racial<br />

differences in susceptibility to infection by mycobacterium<br />

tuberculosis. N. Engl. 1 Med., 322: 422- 427.<br />

Sugisaki K., Dannenberg A.M., Abe Y. et al, (1998): Nonspecific and<br />

immune-specific upregulation <strong>of</strong> cytokines in rabbit dermal<br />

tuberculous (BCG) lesions. 1. Leukoc. Biol., 63: 440- 450.<br />

T attevin P., Casalino E., Fleury L., Egmann G., Ruel M. and Bouvet<br />

E. (1999): The validity <strong>of</strong> medical history classic<br />

<strong>symptoms</strong> and chest radiographs in predicting pulmonary<br />

tuberculosis. Chest, 115: 1248- 1253.<br />

171


Teklu B. (1993) : Symptoms <strong>of</strong> pulmonary tuberculosis in consecutive<br />

).- smear - <strong>positive</strong> cases treated in Ethiopia. Tubercle and<br />

Lung Dis., 74 : 126-128.<br />

Telzak E.E.L. (1997): Tuberlosis and HIV infection. Medelin. North Am.,<br />

81 (2): 345- 60.<br />

Tenover F. C., Crawford J. T., Huebner R. E. et al. (1993): The<br />

resurgence <strong>of</strong> tuberculosis: is your laboratory redy? J. Clin.<br />

Microbiol., 31: 767.<br />

Thomas H., Warren E. and Shermann S. (1988): Sputum examination in<br />

tuberculous patients. Tubercle, 57: 9<br />

Thompson B. C. (1952): Discussion on the fate <strong>of</strong> the tuberculous primary<br />

complex. Proc. Roy. Soc. Med., 41: 741.<br />

Toman K. (1979): Tuberculosis case finding and chemotheraopy<br />

Questions and answers. WHO, Geneva, 9.<br />

Trinchieri G. (1995): Interleukin- 12 and interferon- y. Do they always go<br />

together? Am. 1. Pathol., 147: 1534- 1538.<br />

Trinchieri G. (1997): Cytokines acting on or secreted by macrophages<br />

during intracellular infection (IL- 10, IL- 12, IFN-y ). Curro<br />

Opin. Immunol., 9: 17- 23.<br />

Tsuda T., Dannenberg A.M., Ando M. et al. (1976): Mononuclear cell<br />

turnover in chronic inflammation: Studies on tritiated<br />

thymidine- labeled cells in blood, tuberculin traps, and<br />

172


dermal BCG lesions <strong>of</strong> rabbits. Am. 1. Pathol., 83: 255-<br />

268.<br />

Tsuruta J., Sugisaki K., Dannenberg A.M. et al. (1996): The cytokines<br />

NAP- 1 (Il,-8), MCP- I, IL-I beta, and GRO in rabbit<br />

inflammatory skin lesions produced by the chemical<br />

irritant sulfur mustard. Inflammation, 20: 293- 318.<br />

UdaniP. M., Parikh U. C., Shah P. M. and Naik P. A. (1971): BeG<br />

test in tuberculosis. Indian 1. Pediatr., 8: 143-50.<br />

Ustvedt H.J. (1977): Sex ratio in erythema nodosum. Oslo City Hosp., 27: 9.<br />

Vaddi K., Keller M. and Newton R.C. (1997): The chemokine facts-<br />

Book. San Diego, Academic press.<br />

Van den Brande P., Vijgen J. and Demedts M. (1991): Clinical<br />

spectrum <strong>of</strong>pulmonary tuberculosis in old patients:<br />

Comparison with young patients. 1. Gerontology, 46:<br />

M204- 209.<br />

Van Soolingen D., Hoogenboezem T., De Haas P.E.W., Her-means P.<br />

W.M., Koedam M. A., Teppema K. S., Brennan P.J.,<br />

Besra C.S., Portals F., Top J., Schouls L.M. and Van<br />

Embden J.D.A. (1997): A novel pathogenic taxon <strong>of</strong>the<br />

Mycobacterium tuberculosis complex. Canetti:<br />

characterization <strong>of</strong> an exceptional isolate from Africa. Int.<br />

J. Syst. Bacteriol., 47: 1236- 1245.<br />

Van Soolingen D., van der Zanden A.G.M., De Haas P.E.W.,<br />

Noordhoek G.T., Kiers A., Foudraine N. A., Portaels F.,<br />

173


":\<br />

1ffftrences<br />

Kolk. A.H.J., Kremer K. and van Embden J.D.A.<br />

(1998): Diagnosis <strong>of</strong> Mycobacterium microti infections<br />

<strong>among</strong> humans by using novel genetic markers. J. Clin.<br />

Microbiol., 36: 1840- 1845.<br />

Vestal M., Gross A.S. and Rook G. A. (1989): Role <strong>of</strong> culture in isolation<br />

<strong>of</strong> different mycobacteria. J. Microbiol., 12: 218.<br />

Vordermeier H.M. (1995): T-cell recognition <strong>of</strong>mycobacterial antigens.<br />

Eur. Respir. 1., 8 ( supp20) : 657s-667s.<br />

Wallace J.M., Deutsch A. L., Harrell J.H. and Moser K.M. (1981):<br />

Bronchoscopy and transbronchial biopsy in evaluation <strong>of</strong><br />

patients with suspected active tuberculosis. Am. J. Med.,<br />

70-1189.<br />

Wandwalo E .R. and Merkve O. (2000): Delay in tuberculosis case­<br />

finding and treatment in Mwanza, Tanzania. lnt. J. Tuber.<br />

Lung Dis., 4(2): 133- 138.<br />

Warren N.G. and Body A. B. (1995): Bacteriology and diagnosis. In :<br />

Rossman M.D., Mac Gregor R.R. (eds). Tuberculosis :<br />

Clinical management and new challenges. 35-52, McGraw<br />

Hill Inc.<br />

Weber A. L., Bird K.T. and Janower W.L (1968): Primary tuberculosis<br />

in childhood with particular emphasis on changes affecting<br />

the tracheobronchial tree. Am. J. Roentgenol., 103: 123.<br />

Weyer K (1990): Quality and quantity <strong>of</strong> <strong>sputum</strong> specimens affect<br />

bacteriological findings. Am. Rev. Respir. Dis., 141(4): 789.<br />

174


Whittier P. S., Westfall K., Seterquist S. and Hopfer R.L. (1992):<br />

Evaluation <strong>of</strong> the septichek AFB system in the recovery <strong>of</strong><br />

mycobacterla. Eur. J. Clin. Microbiol. Infect. Dis., 1 1 : 91 5.<br />

WHO (1964): Expert corn~nittee report on tuberculosis: technical report<br />

series, 2 10.<br />

WHO (1994): TB aglobal emergency. WHO report on the TB epidemic.<br />

Geneva. WHO.<br />

WHO (1996): Groups at risk: WHO report on the tuberculosis epidemic.<br />

World Health Organization. Geneva. Switzerland.<br />

Williams M. H., Yoo 0. H. and Kane C. (1973): Pulmonary function in<br />

miliary tuberculosis. Am. Rev. Respir. Dis., 107: 858.<br />

Wilson M. L., Stone B.L., Hildred M. V., et al. (1995): Comparison <strong>of</strong><br />

recovery rates for rnycobacteria fi-om BACTEC 12 B vials,<br />

Middlebrook 7H 1 1 selective biplates and lowenstein-<br />

Jensen stants in a public liealth mycobacteriology<br />

laboratory. J. Clin. Microbiol., 33: 25 16-251 8.<br />

Wilson W., Berie S. V., Fanta S. Y. and Muddrie F. N. (1981): Rapid<br />

diagnosis <strong>of</strong> mycobacteria. Chest, 7:88.<br />

WWW. Adams. Com (2000) : Tuberculosis from A-2.<br />

Yarnashi F., Suzuk K., Sasaki Y. et al. (1996): Prevalence <strong>of</strong> coexisting<br />

diabetes mellitus <strong>among</strong> active pulmonary tuberculosis.<br />

Kekkaku, 71 (10) : 569-572.


Young R.A., Bloom B.R., Grosskinsky C.M. et al. (1985): Dissection <strong>of</strong><br />

M. TB antigens using recombinant DNA. Proc. Natl. Acad.<br />

Sci. USA, 82 : 2583-2587.<br />

Yu G. P., Hsieh C. C. and Peng J. (1988): Rish factors associated with<br />

the prevalence <strong>of</strong> pulmonary tuberclosis <strong>among</strong> sanitary<br />

workers in Sl~anghi. Tubercle, 69: 105- 12.<br />

Yu GP., Hsieh C.C. and Peng J. (1988): Risk factors associated with the<br />

prevalence <strong>of</strong> pulmonary tuberculosis <strong>among</strong> sanitary<br />

works in Shanghai. Tubercle, 69: 105-1 2.<br />

Yuan D., Koh C.Y. and Wilder J. A. (1994): Interaction between B<br />

lymphocytes and NK cells. FASEB J., 8: 10 12- 101 8.<br />

Zack M. B., Fulkerson L.L. and Stein E. (1973): Glucose intolerance in<br />

pulmonary tuberclosis. Am. Rev. Respir. Dis., 108 : 1164.<br />

Zaghloul M. H. (1998): Update tecllnology in diagnosis and drug<br />

susceptibility <strong>of</strong> lnycobacteriuln tuberculosis. Thesis fox<br />

MD degree in chinical pathology, Mansoura university.<br />

Zheng X. and Roberts G. D. (1999): Diagnosis and susceptibility testing.<br />

In tuberculosis and non tuberculous my cobacterial<br />

infections schloss berg D., MD. (eds) 4' edition, W.B<br />

Saunders Company, division <strong>of</strong> Harcourt Brace and<br />

company, London. Ch., 4: PP, 57-.


-t_<br />

APPKNDIX


- 3<br />

I<br />

+ +<br />

W W<br />

z<br />

+<br />

N<br />

E<br />

+<br />

-<br />

E<br />

+<br />

N<br />

z<br />

t<br />

+<br />

2<br />

m m h w u u m u w u u u u p a<br />

Nercu,m4mu,*WNuOu,#$$e%&e5g~;::Y~:;:E<br />

m W - N U + - W + P P N W u W W W W P W N N N W W W W N V I N W<br />

- # ~ W ~ a P ~ ~ u W ~ ~ P ~ N ~ O w 0 0 O m W m W ~ m o O<br />

~ ~ r ~ a w g g ~ ~ ~ ~ v ~ a ~ v<br />

Sex<br />

z ~ g W ~ 3 " L g z g z g Z ~ R Z Z Z z ~ Z t n g z g K v l g Z<br />

Marital<br />

status<br />

~<br />

. . . . . . . .<br />

re<br />

. . . . . .<br />

n<br />

. . . . . . .<br />

0<br />

. . .<br />

0<br />

. . . . . . . .<br />

BCG<br />

u CI c.l "-"'<br />

+ +<br />

N W<br />

5 3<br />

+<br />

-<br />

g<br />

El<br />

er<br />

+ +<br />

r N N<br />

g Z K<br />

f + +<br />

2g2<br />

Jr<br />

2<br />

u<br />

-<br />

z<br />

+<br />

-<br />

Z<br />

-<br />

+<br />

W - N<br />

$ 4 ~<br />

n<br />

-<br />

. . . . . . . . . . . . . . . . . . . . . . . . . . . .<br />

N - A - - - W N - N m W N W W N ' W N W W W P W N W N W<br />

+ + +<br />

2 2 2<br />

+<br />

N<br />

r<br />

7<br />

i.l<br />

$ + +<br />

N W P<br />

z g z~ ~<br />

+ +<br />

EJN<br />

Z <<br />

+<br />

N<br />

4<br />

+ +<br />

N N<br />

< Z<br />

==I<br />

+ f<br />

N<br />

N<br />

g e<br />

3<br />

+<br />

N<br />

Z<br />

+<br />

-<br />

g<br />

-<br />

Z ~ Z K Z Z Z Z Z Y C ~ S Z Z ~ Z<br />

+ +<br />

--<br />

+<br />

N<br />

c<br />

+ +<br />

W N<br />

$ <<br />

--<br />

==<br />

+<br />

- - 9<br />

i + $ +<br />

N - W m<br />

Z Z<br />

+<br />

-<br />

z<br />

S<br />

+<br />

I<br />

+ + + +<br />

W W - -<br />

ggzz<br />

+ + +<br />

- - -<br />

z z z<br />

+<br />

+<br />

c.l 8<br />

+<br />

z<br />

t +<br />

N W<br />

zs<br />

+<br />

N W<br />

5=- .- .1<br />

+ +<br />

W -<br />

+<br />

w -<br />

+<br />

PJ<br />

$<br />

.4<br />

+ +<br />

r t 4<br />

z g<br />

w n<br />

%+"<br />

7<br />

3 E g Z - - 7 5 2<br />

+<br />

r<br />

g<br />

+<br />

-<br />

Z<br />

+<br />

rr<br />

+<br />

W<br />

5:<br />

+<br />

z<br />

+<br />

,7<br />

+<br />

-<br />

+<br />

N<br />

E<br />

+ '<br />

- =1<br />

N -<br />

+<br />

W<br />

+<br />

Z<br />

+<br />

N<br />

z<br />

P.<br />

+<br />

N<br />

z<br />

+<br />

N<br />

%<br />

+<br />

z<br />

+<br />

- W<br />

gq<br />

E Z<br />

+ +<br />

N U<br />

z<br />

+<br />

N<br />

z<br />

+ + t<br />

N N -<br />

z<br />

+<br />

-<br />

+ + + + ' i + t + + f + + + + C<br />

- W W N S W M - N N U W - W N N<br />

+<br />

r<br />

5<br />

-<br />

+<br />

N N<br />


123 1 [M (S )+ ] 13W 1 I+ JIM 1<br />

124 117 IF IS I+ 1 1 1 ~<br />

( ]IM ] 1 1 1 (+ v (I 1 1 (+ (IM<br />

] 1 1<br />

107 51 M M + 11 + Iy + 1) + 6M 11 + 2M + 2M + ]6M<br />

108 21 M s + + 1~ + 3w + 3w + 1 w n + IM 11 + 3w + IM<br />

109 20 F S + + 1M + IM + IW I + +M<br />

110 40 M M + I1 + SM + 4M + 6! + 2M111 + 5! I1 + 2M<br />

111 26 M S + I + 3M + 3M + 2M I<br />

I06 40 F M + + 15M + 15M + 3M + 2> + 2M II + 31 II + - 4M<br />

104 10 F S + + 2M + 15M+ 1M + 3W I<br />

105 19 F S + + 1M + 1WIII + 3W 11 + 2W + 1M<br />

I03 45 F M + + ly + I> + 2y + 2) II ' + 2M + 2M + 6M<br />

94 41 F M + + 2W + 2W II + 2W -t 3W + 1M<br />

95 18 F S + + 3W + 1W + 2W + 4W<br />

96 45 M M -+ H + 6M + 6M + 2M + 1M I + 1M + IM + 2M<br />

97 37 M M + I + 1M + 1M + 1W + 1M + 1M<br />

98 32 M M + H + 2M + 2M + 1M + 1M I + 2M 11 + 2M<br />

99 46 M M + I1 + 1M + 1M + 2W II + 3W + 3W<br />

100 50 F M + + 2M + 15M + IM I + IjM+ 18M + 2M<br />

101 20 F M -.re + 5M + 5M + 2M I1 + 2M<br />

102 44 M M + I1 + 3M + 3M + 2M + 2M + 2M<br />

tz e~ a 0 P . B o a e a 0 crr3 f o _ c ' o x O<br />

~3 o e c m<br />

0 % 1 5 5 g s e a ,, Z 2' Mg 5<br />

W a 6 a a a o o u L z,cl a a<br />

VI<br />

0: 2 VI<br />

- e c c h C: crl c c<br />

0<br />

2 G<br />

d 0 w<br />

N<br />

- J 5 4J .!A<br />

V1<br />

- coc - O c : S e<br />

I Smear +we<br />

forAFB cases

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!